action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,,33943,[],CHEMBL751769,The compound was evaluated for antagonistic activity at P2Y purinoceptor 1 (P2Y1) from guinea pig taenia coli,F,,,BAO_0000190,BAO_0000019,assay format,Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2S(=O)(=O)[O-])c2c1C(=O)c1ccccc1C2=O.[Na+].[Na+],,,CHEMBL1135773,J Med Chem,2002,,CHEMBL133572,,CHEMBL1205686,,0,http://www.openphacts.org/units/Nanomolar,252112,<,1,1,<,,IC50,nM,,1000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.0
,,68995,[],CHEMBL751769,The compound was evaluated for antagonistic activity at P2Y purinoceptor 1 (P2Y1) from guinea pig taenia coli,F,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(C)c(Nc2cc(S(=O)(=O)[O-])c(N)c3c2C(=O)c2ccccc2C3=O)c(C)c1.[Na+],,,CHEMBL1135773,J Med Chem,2002,,CHEMBL133576,ACID BLUE 129,CHEMBL1205687,5.52,0,http://www.openphacts.org/units/Nanomolar,252115,=,1,1,=,,IC50,nM,,3000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,3.0
,,989362,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc([Se]C)nc2c1ncn2C1CC(OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL356041,,CHEMBL356041,6.42,0,http://www.openphacts.org/units/Nanomolar,285219,=,1,1,=,,IC50,nM,,377.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,377.0
,,989364,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CCCCCCc1nc(NC)c2ncn([C@H]3C[C@H](OP(=O)(O)O)[C@]4(COP(=O)(O)O)C[C@H]34)c2n1,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL2112869,,CHEMBL2112869,6.34,0,http://www.openphacts.org/units/Nanomolar,285217,=,1,1,=,,IC50,nM,,452.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,452.0
,,993873,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc(F)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL2112868,,CHEMBL2112868,6.45,0,http://www.openphacts.org/units/Nanomolar,285220,=,1,1,=,,IC50,nM,,356.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,356.0
,,996429,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL2112863,,CHEMBL2112863,6.80,0,http://www.openphacts.org/units/Nanomolar,285225,=,1,1,=,,IC50,nM,,157.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,157.0
,,996431,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc(Br)nc2c1ncn2C1CC(OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL146342,,CHEMBL146342,7.43,0,http://www.openphacts.org/units/Nanomolar,285222,=,1,1,=,,IC50,nM,,37.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,37.0
,,996433,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc(C)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL2112867,,CHEMBL2112867,7.31,0,http://www.openphacts.org/units/Nanomolar,285218,=,1,1,=,,IC50,nM,,49.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,49.0
,,997651,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc(SC)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL2112865,,CHEMBL2112865,6.66,0,http://www.openphacts.org/units/Nanomolar,285223,=,1,1,=,,IC50,nM,,221.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,221.0
,,998943,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CSc1nc(N)c2ncn([C@H]3C[C@H](OP(=O)(O)O)[C@]4(COP(=O)(O)O)C[C@H]34)c2n1,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL2112861,,CHEMBL2112861,6.43,0,http://www.openphacts.org/units/Nanomolar,285226,=,1,1,=,,IC50,nM,,367.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,367.0
,,1010097,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CCCC/C=C/c1nc(NC)c2ncn([C@H]3C[C@H](OP(=O)(O)O)[C@]4(COP(=O)(O)O)C[C@H]34)c2n1,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL2112866,,CHEMBL2112866,5.73,0,http://www.openphacts.org/units/Nanomolar,285216,=,1,1,=,,IC50,nM,,1870.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,1870.0
,,1013713,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CCCC/C=C\c1nc(NC)c2ncn([C@H]3C[C@H](OP(=O)(O)O)[C@]4(COP(=O)(O)O)C[C@H]34)c2n1,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL2112007,,CHEMBL2112007,5.62,0,http://www.openphacts.org/units/Nanomolar,285215,=,1,1,=,,IC50,nM,,2400.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,2400.0
,,1021753,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(I)nc2c1ncn2C1CC(OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL343651,,CHEMBL343651,7.06,0,http://www.openphacts.org/units/Nanomolar,285214,=,1,1,=,,IC50,nM,,87.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,87.0
,,1025402,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL2112864,,CHEMBL2112864,7.28,1,http://www.openphacts.org/units/Nanomolar,285221,=,1,1,=,,IC50,nM,,52.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,52.0
,,1026616,[],CHEMBL750159,Antagonistic activity against P2Y purinoceptor 1,F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc(I)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145892,J Med Chem,2003,,CHEMBL444278,,CHEMBL444278,8.08,0,http://www.openphacts.org/units/Nanomolar,285224,=,1,1,=,,IC50,nM,,8.4,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,8.4
,,1473884,[],CHEMBL832660,Inhibition concentration required against human Y306F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '13.61', 'le': '0.30', 'lle': '7.46', 'sei': '2.77'}",CHEMBL435402,,CHEMBL435402,6.44,0,http://www.openphacts.org/units/Nanomolar,381026,=,1,1,=,,IC50,nM,,360.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,360.0
,,1474016,[],CHEMBL830858,Inhibition concentration required against wild type strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]-MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '16.10', 'le': '0.36', 'lle': '8.64', 'sei': '3.28'}",CHEMBL435402,,CHEMBL435402,7.62,0,http://www.openphacts.org/units/Nanomolar,381026,=,1,1,=,,IC50,nM,,24.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,24.0
,,1474027,[],CHEMBL832377,Inhibition concentration required against human Y203A (EL2) mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1,,,CHEMBL1137222,J Med Chem,2004,,CHEMBL435402,,CHEMBL435402,,0,http://www.openphacts.org/units/Nanomolar,381026,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,10000.0
,,1474034,[],CHEMBL832656,Inhibition concentration required against human Y203F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '13.91', 'le': '0.31', 'lle': '7.61', 'sei': '2.83'}",CHEMBL435402,,CHEMBL435402,6.58,0,http://www.openphacts.org/units/Nanomolar,381026,=,1,1,=,,IC50,nM,,260.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,260.0
,,1474146,[],CHEMBL832657,Inhibition concentration required against human Y273A mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]-MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '16.18', 'le': '0.36', 'lle': '8.68', 'sei': '3.29'}",CHEMBL435402,,CHEMBL435402,7.66,0,http://www.openphacts.org/units/Nanomolar,381026,=,1,1,=,,IC50,nM,,22.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,22.0
,,1474147,[],CHEMBL832658,Inhibition concentration required against human Y273F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '15.63', 'le': '0.35', 'lle': '8.42', 'sei': '3.18'}",CHEMBL435402,,CHEMBL435402,7.40,0,http://www.openphacts.org/units/Nanomolar,381026,=,1,1,=,,IC50,nM,,40.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,40.0
,,1474148,[],CHEMBL832659,Inhibition concentration required against human Y306A mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '14.42', 'le': '0.32', 'lle': '7.84', 'sei': '2.93'}",CHEMBL435402,,CHEMBL435402,6.82,0,http://www.openphacts.org/units/Nanomolar,381026,=,1,1,=,,IC50,nM,,150.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,150.0
,,1474149,[],CHEMBL830858,Inhibition concentration required against wild type strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]-MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '15.70', 'le': '0.34', 'lle': '6.94', 'sei': '3.37'}",CHEMBL129841,,CHEMBL129841,6.68,0,http://www.openphacts.org/units/Nanomolar,381052,=,1,1,=,,IC50,nM,,210.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,210.0
,,1474150,[],CHEMBL832377,Inhibition concentration required against human Y203A (EL2) mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '14.42', 'le': '0.31', 'lle': '6.39', 'sei': '3.09'}",CHEMBL129841,,CHEMBL129841,6.13,0,http://www.openphacts.org/units/Nanomolar,381052,=,1,1,=,,IC50,nM,,740.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,740.0
,,1474151,[],CHEMBL832656,Inhibition concentration required against human Y203F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '15.24', 'le': '0.33', 'lle': '6.74', 'sei': '3.27'}",CHEMBL129841,,CHEMBL129841,6.48,1,http://www.openphacts.org/units/Nanomolar,381052,=,1,1,=,,IC50,nM,,330.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,330.0
,,1474152,[],CHEMBL832657,Inhibition concentration required against human Y273A mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]-MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '14.86', 'le': '0.32', 'lle': '6.58', 'sei': '3.19'}",CHEMBL129841,,CHEMBL129841,6.32,0,http://www.openphacts.org/units/Nanomolar,381052,=,1,1,=,,IC50,nM,,480.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,480.0
,,1474153,[],CHEMBL832658,Inhibition concentration required against human Y273F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '14.53', 'le': '0.31', 'lle': '6.44', 'sei': '3.12'}",CHEMBL129841,,CHEMBL129841,6.18,0,http://www.openphacts.org/units/Nanomolar,381052,=,1,1,=,,IC50,nM,,660.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,660.0
,,1474154,[],CHEMBL832659,Inhibition concentration required against human Y306A mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '15.27', 'le': '0.33', 'lle': '6.75', 'sei': '3.27'}",CHEMBL129841,,CHEMBL129841,6.50,0,http://www.openphacts.org/units/Nanomolar,381052,=,1,1,=,,IC50,nM,,320.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,320.0
,,1474155,[],CHEMBL832660,Inhibition concentration required against human Y306F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand,B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL1137222,J Med Chem,2004,"{'bei': '14.13', 'le': '0.30', 'lle': '6.27', 'sei': '3.03'}",CHEMBL129841,,CHEMBL129841,6.01,0,http://www.openphacts.org/units/Nanomolar,381052,=,1,1,=,,IC50,nM,,980.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,980.0
,,1610565,[],CHEMBL872179,Inhibitory concentration against P2Y purinoceptor 1 expressed in 1321N1 astrocytoma Cells; (n=3),B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)[O-])c4cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c34)ccc2F)c1)Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)[O-])c4cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c34)ccc2F)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1140384,J Med Chem,2005,,CHEMBL413145,,CHEMBL1207514,,0,http://www.openphacts.org/units/Nanomolar,403192,=,1,1,=,,IC50,nM,,1819700.86,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,Log IC50,,UO_0000065,,-2.74
,,1905969,[],CHEMBL888517,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-induced inositol phosphate formation,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(I)nc2c1ncn2CC(CP(=O)(O)O)CP(=O)(O)O,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL227235,,CHEMBL227235,6.10,0,http://www.openphacts.org/units/Nanomolar,644057,=,1,1,=,,IC50,nM,,790.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,790.0
,,1905970,[],CHEMBL888517,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-induced inositol phosphate formation,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(Cl)nc2c1ncn2CC(CP(=O)(O)O)CP(=O)(O)O,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL153254,,CHEMBL153254,6.21,0,http://www.openphacts.org/units/Nanomolar,644056,=,1,1,=,,IC50,nM,,620.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,620.0
,,1905971,[],CHEMBL888517,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-induced inositol phosphate formation,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(I)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(CO)C[C@H]12,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL375022,,CHEMBL375022,5.81,0,http://www.openphacts.org/units/Nanomolar,644055,=,1,1,=,,IC50,nM,,1560.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,1560.0
,,1905972,[],CHEMBL888517,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-induced inositol phosphate formation,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(-c2ccccc2)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL435930,,CHEMBL435930,5.71,0,http://www.openphacts.org/units/Nanomolar,644054,=,1,1,=,,IC50,nM,,1940.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,1940.0
,,1905973,[],CHEMBL888517,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-induced inositol phosphate formation,F,,,BAO_0000190,BAO_0000219,cell-based format,C#Cc1nc(NC)c2ncn([C@H]3C[C@H](OP(=O)(O)O)[C@]4(COP(=O)(O)O)C[C@H]34)c2n1,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL390149,,CHEMBL390149,7.03,0,http://www.openphacts.org/units/Nanomolar,644053,=,1,1,=,,IC50,nM,,93.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,93.0
,,1905974,[],CHEMBL888517,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-induced inositol phosphate formation,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(C(=O)O)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL226857,,CHEMBL226857,6.06,0,http://www.openphacts.org/units/Nanomolar,644052,=,1,1,=,,IC50,nM,,870.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,870.0
,,1905975,[],CHEMBL888517,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-induced inositol phosphate formation,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(C(N)=O)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL226807,,CHEMBL226807,5.76,0,http://www.openphacts.org/units/Nanomolar,644051,=,1,1,=,,IC50,nM,,1750.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,1750.0
,,1905976,[],CHEMBL888517,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-induced inositol phosphate formation,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(C#N)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL375682,,CHEMBL375682,5.16,0,http://www.openphacts.org/units/Nanomolar,644050,=,1,1,=,,IC50,nM,,6900.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,6900.0
,,1905977,[],CHEMBL888518,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-stimulated PLC activity,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(C#N)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL375682,,CHEMBL375682,5.16,0,http://www.openphacts.org/units/Nanomolar,644050,=,1,1,=,,IC50,nM,,6918.31,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,Log IC50,,UO_0000065,,-5.16
,,1905978,[],CHEMBL888518,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-stimulated PLC activity,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(I)nc2c1ncn2CC(CP(=O)(O)O)CP(=O)(O)O,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL227235,,CHEMBL227235,6.10,0,http://www.openphacts.org/units/Nanomolar,644057,=,1,1,=,,IC50,nM,,794.33,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,Log IC50,,UO_0000065,,-6.1
,,1905979,[],CHEMBL888518,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-stimulated PLC activity,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(Cl)nc2c1ncn2CC(CP(=O)(O)O)CP(=O)(O)O,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL153254,,CHEMBL153254,6.21,0,http://www.openphacts.org/units/Nanomolar,644056,=,1,1,=,,IC50,nM,,616.6,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,Log IC50,,UO_0000065,,-6.21
,,1905980,[],CHEMBL888518,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-stimulated PLC activity,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(I)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(CO)C[C@H]12,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL375022,,CHEMBL375022,5.81,0,http://www.openphacts.org/units/Nanomolar,644055,=,1,1,=,,IC50,nM,,1548.82,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,Log IC50,,UO_0000065,,-5.81
,,1905981,[],CHEMBL888518,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-stimulated PLC activity,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(-c2ccccc2)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL435930,,CHEMBL435930,5.71,0,http://www.openphacts.org/units/Nanomolar,644054,=,1,1,=,,IC50,nM,,1949.84,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,Log IC50,,UO_0000065,,-5.71
,,1905982,[],CHEMBL888518,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-stimulated PLC activity,F,,,BAO_0000190,BAO_0000219,cell-based format,C#Cc1nc(NC)c2ncn([C@H]3C[C@H](OP(=O)(O)O)[C@]4(COP(=O)(O)O)C[C@H]34)c2n1,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL390149,,CHEMBL390149,7.03,0,http://www.openphacts.org/units/Nanomolar,644053,=,1,1,=,,IC50,nM,,93.33,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,Log IC50,,UO_0000065,,-7.03
,,1905983,[],CHEMBL888518,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-stimulated PLC activity,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(C(=O)O)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL226857,,CHEMBL226857,6.06,0,http://www.openphacts.org/units/Nanomolar,644052,=,1,1,=,,IC50,nM,,870.96,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,Log IC50,,UO_0000065,,-6.06
,,1905984,[],CHEMBL888518,Antagonist activity at human P2Y1 receptor expressed in 1321N1 cells assessed as inhibition of 2-MeS-ADP-stimulated PLC activity,F,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(C(N)=O)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL1145411,J Med Chem,2007,,CHEMBL226807,,CHEMBL226807,5.76,0,http://www.openphacts.org/units/Nanomolar,644051,=,1,1,=,,IC50,nM,,1737.8,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,Log IC50,,UO_0000065,,-5.76
,,1969315,[],CHEMBL896521,Inhibition of P2Y1 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=[N+]([O-])c1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Oc1ccccc1)N2,,,CHEMBL1149534,Bioorg Med Chem Lett,2007,,CHEMBL399203,,CHEMBL399203,,0,http://www.openphacts.org/units/Nanomolar,658073,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,2592920,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)c1ccc([N+](=O)[O-])cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL453637,,CHEMBL453637,5.80,0,http://www.openphacts.org/units/Nanomolar,725445,=,1,1,=,,IC50,nM,,1600.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.6
,,2592922,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CC[C@H](Nc3ccccc3)c3ccccc32)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL473715,,CHEMBL473715,,0,http://www.openphacts.org/units/Nanomolar,724664,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,2592923,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2C[C@@H](C)[C@H](Nc3ccccc3)c3ccccc32)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL473509,,CHEMBL473509,5.00,0,http://www.openphacts.org/units/Nanomolar,724663,=,1,1,=,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
,,2592924,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1C[C@@H](Nc2ccccc2)c2ccccc2N1C(=O)c1ccc(OC)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL473095,,CHEMBL473095,,0,http://www.openphacts.org/units/Nanomolar,724662,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,2592925,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1C[C@H](Nc2ccccc2)c2ccccc2N1C(=O)c1ccc(OC)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL516508,,CHEMBL516508,5.50,0,http://www.openphacts.org/units/Nanomolar,724578,=,1,1,=,,IC50,nM,,3200.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,3.2
,,2592926,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1cc(Cl)cc(Cl)c1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL462373,,CHEMBL462373,6.22,0,http://www.openphacts.org/units/Nanomolar,724577,=,1,1,=,,IC50,nM,,600.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.6
,,2592927,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1cc(OC)cc(OC)c1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL461326,,CHEMBL461326,6.10,0,http://www.openphacts.org/units/Nanomolar,724576,=,1,1,=,,IC50,nM,,800.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.8
,,2592928,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1ccccc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL461325,,CHEMBL461325,5.80,0,http://www.openphacts.org/units/Nanomolar,724575,=,1,1,=,,IC50,nM,,1600.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.6
,,2592929,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1cccc(Br)c1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL462369,,CHEMBL462369,6.00,0,http://www.openphacts.org/units/Nanomolar,724494,=,1,1,=,,IC50,nM,,1000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.0
,,2592930,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1ccc(OC)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL462368,,CHEMBL462368,5.22,0,http://www.openphacts.org/units/Nanomolar,724493,=,1,1,=,,IC50,nM,,6000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,6.0
,,2592931,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1cccc(OC)c1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL518823,,CHEMBL518823,5.80,0,http://www.openphacts.org/units/Nanomolar,724492,=,1,1,=,,IC50,nM,,1600.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.6
,,2592932,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1ccc(Cl)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL462367,,CHEMBL462367,5.70,0,http://www.openphacts.org/units/Nanomolar,724491,=,1,1,=,,IC50,nM,,2000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.0
,,2592933,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1cccc(Cl)c1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL454913,,CHEMBL454913,6.00,0,http://www.openphacts.org/units/Nanomolar,724319,=,1,1,=,,IC50,nM,,1000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.0
,,2592934,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1ccccc1Cl,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL454911,,CHEMBL454911,,0,http://www.openphacts.org/units/Nanomolar,724235,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,2592935,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)c1ccccc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL509206,,CHEMBL509206,4.60,0,http://www.openphacts.org/units/Nanomolar,724233,=,1,1,=,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,2592936,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)c1ccc(Br)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL454910,,CHEMBL454910,6.10,0,http://www.openphacts.org/units/Nanomolar,724232,=,1,1,=,,IC50,nM,,800.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.8
,,2592937,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)c1ccc(OC(F)(F)F)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL518042,,CHEMBL518042,6.00,0,http://www.openphacts.org/units/Nanomolar,725528,=,1,1,=,,IC50,nM,,1000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.0
,,2592938,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)c1ccc(Cl)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL461532,,CHEMBL461532,5.89,0,http://www.openphacts.org/units/Nanomolar,725527,=,1,1,=,,IC50,nM,,1300.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.3
,,2592939,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)c1ccc(OC)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL518040,,CHEMBL518040,6.10,0,http://www.openphacts.org/units/Nanomolar,725526,=,1,1,=,,IC50,nM,,800.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.8
,,2592940,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)c1cccc(OC(F)(F)F)c1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL461356,,CHEMBL461356,,0,http://www.openphacts.org/units/Nanomolar,725525,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,2592960,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](N(C)c2ccccc2)c2ccccc2N1C(=O)c1ccc(OC)cc1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL454669,,CHEMBL454669,,0,http://www.openphacts.org/units/Nanomolar,724234,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,2592962,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1[C@H](C)[C@@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1cc(Cl)cc(Cl)c1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL473716,,CHEMBL473716,,0,http://www.openphacts.org/units/Nanomolar,724666,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,25000.0
,,2592965,[],CHEMBL965598,Antagonist activity at human P2Y1 receptor in HEK293 cells assessed as intracellular calcium level by FLIPR,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)Nc1cc(Cl)cc(Cl)c1,,,CHEMBL1152131,Bioorg Med Chem Lett,2008,,CHEMBL462373,,CHEMBL462373,6.22,0,http://www.openphacts.org/units/Nanomolar,724665,=,1,1,=,,IC50,nM,,600.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,600.0
,,3287857,[],CHEMBL1107395,Antagonist activity at P2Y1 receptor by [35S]GTPgammaS binding assay,F,,,BAO_0000190,BAO_0000019,assay format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1.N.N,,,CHEMBL1157778,J Med Chem,2010,,CHEMBL1096400,,CHEMBL129841,6.29,0,http://www.openphacts.org/units/Nanomolar,908358,=,1,1,=,,IC50,nM,,508.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,508.0
,,3352649,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1cccc2cc(-c3cccc(C(F)(F)F)c3)oc12,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1169986,,CHEMBL1169986,,0,http://www.openphacts.org/units/Nanomolar,922154,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,3352650,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1cccc2cc(-c3ccccc3C(F)(F)F)oc12,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1172138,,CHEMBL1172138,5.20,0,http://www.openphacts.org/units/Nanomolar,922155,=,1,1,=,,IC50,nM,,6300.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,6.3
,,3352651,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccccc1-c1cc2cccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)c2o1,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1172139,,CHEMBL1172139,5.40,0,http://www.openphacts.org/units/Nanomolar,922156,=,1,1,=,,IC50,nM,,4000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,4.0
,,3352652,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccccc1-c1cc2cccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)c2o1,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1170183,,CHEMBL1170183,5.40,0,http://www.openphacts.org/units/Nanomolar,922234,=,1,1,=,,IC50,nM,,4000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,4.0
,,3352653,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1cccc2cc(-c3ccccc3Cl)oc12,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1172141,,CHEMBL1172141,,0,http://www.openphacts.org/units/Nanomolar,922235,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,3352654,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Oc1ccccc1-c1cc2cccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)c2o1,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1172338,,CHEMBL1172338,,0,http://www.openphacts.org/units/Nanomolar,922236,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,3352655,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(NC(=O)Nc2cccc3cc(-c4ccccc4C(C)C)oc23)cc1C(F)(F)F,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1172339,,CHEMBL1172339,5.80,0,http://www.openphacts.org/units/Nanomolar,922237,=,1,1,=,,IC50,nM,,1600.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.6
,,3352656,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCc1ccc(NC(=O)Nc2cccc3cc(-c4ccccc4C(C)C)oc23)cc1,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1169909,,CHEMBL1169909,6.20,0,http://www.openphacts.org/units/Nanomolar,921148,=,1,1,=,,IC50,nM,,630.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.63
,,3352657,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccccc1-c1cc2cccc(NC(=O)Nc3ccc(C(C)(C)C)cc3)c2o1,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1172466,,CHEMBL1172466,5.89,0,http://www.openphacts.org/units/Nanomolar,921149,=,1,1,=,,IC50,nM,,1300.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.3
,,3352658,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCCOc1ccc(NC(=O)Nc2cccc3cc(-c4ccccc4C(C)C)oc23)cc1,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1170327,,CHEMBL1170327,5.70,0,http://www.openphacts.org/units/Nanomolar,921150,=,1,1,=,,IC50,nM,,2000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.0
,,3352659,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccccc1-c1cc2cccc(NC(=O)Nc3ccc(Cl)cc3)c2o1,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1170328,,CHEMBL1170328,5.70,0,http://www.openphacts.org/units/Nanomolar,921151,=,1,1,=,,IC50,nM,,2000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.0
,,3352660,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccccc1-c1cc2cccc(NC(=O)Nc3ccc(N(C)C)cc3)c2o1,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1171352,,CHEMBL1171352,4.80,0,http://www.openphacts.org/units/Nanomolar,921219,=,1,1,=,,IC50,nM,,15800.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,15.8
,,3352661,[],CHEMBL1175619,Antagonist activity at P2Y1 expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccccc1-c1cc2cccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c2o1,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,,CHEMBL1171536,,CHEMBL1171536,5.30,0,http://www.openphacts.org/units/Nanomolar,921220,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,5.0
,,3352672,[],CHEMBL1175620,Displacement of [33P]2-MeS-ADP from human P2Y1 receptor expressed in human U2OS cells by scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccccc1-c1cc2cccc(NC(=O)Nc3ccc(C(C)(C)C)cc3)c2o1,,,CHEMBL1177808,Bioorg Med Chem Lett,2010,"{'bei': '15.29', 'le': '0.28', 'lle': '-1.64', 'sei': '12.02'}",CHEMBL1172466,,CHEMBL1172466,6.52,0,http://www.openphacts.org/units/Nanomolar,921149,=,1,1,=,,IC50,nM,,300.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,300.0
,,10987809,[],CHEMBL2072726,Antagonist activity at human P2Y1R expressed in human 1321N1 cells assessed as inhibition of 2-MeSADP-induced increase in intracellular inositol phosphate generation,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1noc(NS(=O)(=O)c2ccc(NC(=O)Nc3ccc(Cl)c(Cl)c3)cc2)c1C,,,CHEMBL2069288,Bioorg Med Chem,2012,,CHEMBL1518422,,CHEMBL1518422,6.85,0,http://www.openphacts.org/units/Nanomolar,1663966,=,1,1,=,,IC50,nM,,140.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.14
,,10987810,[],CHEMBL2072726,Antagonist activity at human P2Y1R expressed in human 1321N1 cells assessed as inhibition of 2-MeSADP-induced increase in intracellular inositol phosphate generation,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(NC(=O)Nc2ccc(S(=O)(=O)Nc3onc(C)c3C)cc2)cc1C,,,CHEMBL2069288,Bioorg Med Chem,2012,,CHEMBL2071539,,CHEMBL2071539,6.89,0,http://www.openphacts.org/units/Nanomolar,1663979,=,1,1,=,,IC50,nM,,130.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.13
,,13879381,[],CHEMBL3107684,Displacement of [33P]-2MeS-ADP from human P2Y1 receptor expressed in HEK293 cells after 1 hr by scintillation counting analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1cccnc1-c1cc2ccccc2[nH]1,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '16.11', 'le': '0.30', 'lle': '0.87', 'sei': '8.41'}",CHEMBL3103623,,CHEMBL3103623,6.64,0,http://www.openphacts.org/units/Nanomolar,1958371,=,1,1,=,,IC50,nM,,227.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,227.0
,,13879384,[],CHEMBL3107684,Displacement of [33P]-2MeS-ADP from human P2Y1 receptor expressed in HEK293 cells after 1 hr by scintillation counting analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1-c1cc2ccccc2[nH]1,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '17.32', 'le': '0.32', 'lle': '0.74', 'sei': '10.77'}",CHEMBL3103624,,CHEMBL3103624,7.12,0,http://www.openphacts.org/units/Nanomolar,1958372,=,1,1,=,,IC50,nM,,75.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,75.0
,Not Determined,13879402,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104632,,CHEMBL3104632,,0,,1959649,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879403,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)NC(=O)N1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104631,,CHEMBL3104631,,0,,1959648,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879404,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,COCCN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104629,,CHEMBL3104629,,0,,1959646,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879405,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCN(CCO)CC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104628,,CHEMBL3104628,,0,,1959645,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879406,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(O)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104627,,CHEMBL3104627,,0,,1959644,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879407,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCNCC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104626,,CHEMBL3104626,,0,,1959643,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879410,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(C1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3105201,,CHEMBL3105201,,0,,1960346,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879411,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCCC2(C1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3105200,,CHEMBL3105200,,0,,1960345,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879412,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1cccnc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3105196,,CHEMBL3105196,,0,,1960341,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879413,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCNCC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104626,,CHEMBL3104626,,0,,1959643,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879414,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCCC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103636,,CHEMBL3103636,,0,,1958386,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879415,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103634,,CHEMBL3103634,,0,,1958384,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879416,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103625,,CHEMBL3103625,,0,,1958374,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879417,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104632,,CHEMBL3104632,,0,,1959649,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879418,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCN(CCO)CC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104628,,CHEMBL3104628,,0,,1959645,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879419,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(O)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104627,,CHEMBL3104627,,0,,1959644,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879420,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCNCC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104626,,CHEMBL3104626,,0,,1959643,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,13879421,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CCCCc2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103628,,CHEMBL3103628,,0,,1958378,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,,13879429,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ncccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3105198,,CHEMBL3105198,6.30,0,http://www.openphacts.org/units/Nanomolar,1960343,=,1,1,=,,IC50,nM,,503.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,503.0
,,13879432,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccncc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3105197,,CHEMBL3105197,6.46,0,http://www.openphacts.org/units/Nanomolar,1960342,=,1,1,=,,IC50,nM,,346.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,346.0
,,13879459,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,COC(=O)N1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '7.89', 'le': '0.15', 'lle': '-2.21', 'sei': '5.13'}",CHEMBL3104630,,CHEMBL3104630,4.27,0,http://www.openphacts.org/units/Nanomolar,1959647,=,1,1,=,,IC50,nM,,54200.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,54.2
,,13879470,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)N1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '8.64', 'le': '0.16', 'lle': '-2.59', 'sei': '7.98'}",CHEMBL3104633,,CHEMBL3104633,4.54,0,http://www.openphacts.org/units/Nanomolar,1959650,=,1,1,=,,IC50,nM,,29200.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,29.2
,,13879471,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)c1ccccc1Oc1ncccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL2333770,,CHEMBL2333770,7.54,0,http://www.openphacts.org/units/Nanomolar,1958373,=,1,1,=,,IC50,nM,,29.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,29.0
,,13879475,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,COCCN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '8.50', 'le': '0.16', 'lle': '-1.76', 'sei': '6.95'}",CHEMBL3104629,,CHEMBL3104629,4.59,0,http://www.openphacts.org/units/Nanomolar,1959646,=,1,1,=,,IC50,nM,,25400.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.4
,,13880370,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCN(Cc3ccccc3)CC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '8.26', 'le': '0.15', 'lle': '-3.18', 'sei': '8.32'}",CHEMBL3104635,,CHEMBL3104635,4.73,0,http://www.openphacts.org/units/Nanomolar,1959652,=,1,1,=,,IC50,nM,,18600.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,18.6
,,13880372,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(C1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '8.79', 'le': '0.17', 'lle': '-2.64', 'sei': '8.33'}",CHEMBL3105201,,CHEMBL3105201,4.73,0,http://www.openphacts.org/units/Nanomolar,1960346,=,1,1,=,,IC50,nM,,18500.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,18.5
,,13880375,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1cccnc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '8.71', 'le': '0.16', 'lle': '-2.34', 'sei': '6.91'}",CHEMBL3105196,,CHEMBL3105196,4.82,0,http://www.openphacts.org/units/Nanomolar,1960341,=,1,1,=,,IC50,nM,,15100.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,15.1
,,13880379,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CCN(c2ncccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '10.85', 'le': '0.21', 'lle': '-1.49', 'sei': '7.45'}",CHEMBL3103627,,CHEMBL3103627,4.96,0,http://www.openphacts.org/units/Nanomolar,1958377,=,1,1,=,,IC50,nM,,11100.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,11.1
,,13880380,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1cnccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3105195,,CHEMBL3105195,7.97,0,http://www.openphacts.org/units/Nanomolar,1960340,=,1,1,=,,IC50,nM,,10.7,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,10.7
,,13880381,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103635,,CHEMBL3103635,7.98,0,http://www.openphacts.org/units/Nanomolar,1958385,=,1,1,=,,IC50,nM,,10.5,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,10.5
,,13880382,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CCN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3105199,,CHEMBL3105199,8.00,0,http://www.openphacts.org/units/Nanomolar,1960344,=,1,1,=,,IC50,nM,,9.9,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,9.9
,,13880385,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '9.39', 'le': '0.18', 'lle': '-2.31', 'sei': '8.89'}",CHEMBL3104634,,CHEMBL3104634,5.06,0,http://www.openphacts.org/units/Nanomolar,1959651,=,1,1,=,,IC50,nM,,8800.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,8.8
,,13880387,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '11.49', 'le': '0.22', 'lle': '-1.59', 'sei': '9.46'}",CHEMBL3103625,,CHEMBL3103625,5.07,0,http://www.openphacts.org/units/Nanomolar,1958374,=,1,1,=,,IC50,nM,,8500.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,8.5
,,13880394,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CCN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '9.18', 'le': '0.17', 'lle': '-2.95', 'sei': '9.15'}",CHEMBL3105199,,CHEMBL3105199,5.20,0,http://www.openphacts.org/units/Nanomolar,1960344,=,1,1,=,,IC50,nM,,6300.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,6.3
,,13880397,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCN(C(=O)OCc3ccccc3)CC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104625,,CHEMBL3104625,8.23,0,http://www.openphacts.org/units/Nanomolar,1959642,=,1,1,=,,IC50,nM,,5.9,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,5.9
,,13880399,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,COC(=O)N1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '9.69', 'le': '0.18', 'lle': '-1.24', 'sei': '6.30'}",CHEMBL3104630,,CHEMBL3104630,5.24,0,http://www.openphacts.org/units/Nanomolar,1959647,=,1,1,=,,IC50,nM,,5800.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,5.8
,,13880408,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '9.61', 'le': '0.18', 'lle': '-2.45', 'sei': '9.34'}",CHEMBL3104636,,CHEMBL3104636,5.31,0,http://www.openphacts.org/units/Nanomolar,1959653,=,1,1,=,,IC50,nM,,4900.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,4.9
,,13880409,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)N1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '10.16', 'le': '0.19', 'lle': '-1.79', 'sei': '9.37'}",CHEMBL3104633,,CHEMBL3104633,5.33,0,http://www.openphacts.org/units/Nanomolar,1959650,=,1,1,=,,IC50,nM,,4700.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,4.7
,,13880417,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '11.88', 'le': '0.22', 'lle': '-1.41', 'sei': '10.05'}",CHEMBL3103635,,CHEMBL3103635,5.39,0,http://www.openphacts.org/units/Nanomolar,1958385,=,1,1,=,,IC50,nM,,4100.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,4.1
,,13880418,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1cnccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '9.75', 'le': '0.18', 'lle': '-1.76', 'sei': '7.74'}",CHEMBL3105195,,CHEMBL3105195,5.40,0,http://www.openphacts.org/units/Nanomolar,1960340,=,1,1,=,,IC50,nM,,4000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,4.0
,,13880420,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCN(Cc3ccccc3)CC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '9.57', 'le': '0.18', 'lle': '-2.43', 'sei': '9.64'}",CHEMBL3104635,,CHEMBL3104635,5.48,0,http://www.openphacts.org/units/Nanomolar,1959652,=,1,1,=,,IC50,nM,,3300.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,3.3
,,13880425,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104636,,CHEMBL3104636,8.60,0,http://www.openphacts.org/units/Nanomolar,1959653,=,1,1,=,,IC50,nM,,2.5,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,2.5
,,13880426,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCCC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '12.02', 'le': '0.23', 'lle': '-1.57', 'sei': '10.48'}",CHEMBL3103636,,CHEMBL3103636,5.62,0,http://www.openphacts.org/units/Nanomolar,1958386,=,1,1,=,,IC50,nM,,2400.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.4
,,13880428,[],CHEMBL3107682,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCCCC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104624,,CHEMBL3104624,8.66,0,http://www.openphacts.org/units/Nanomolar,1959641,=,1,1,=,,IC50,nM,,2.2,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,2.2
,,13880429,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '10.50', 'le': '0.20', 'lle': '-1.71', 'sei': '9.95'}",CHEMBL3104634,,CHEMBL3104634,5.66,0,http://www.openphacts.org/units/Nanomolar,1959651,=,1,1,=,,IC50,nM,,2200.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.2
,,13880430,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CCN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '12.42', 'le': '0.23', 'lle': '-1.39', 'sei': '10.56'}",CHEMBL3102866,,CHEMBL3102866,5.66,0,http://www.openphacts.org/units/Nanomolar,1958376,=,1,1,=,,IC50,nM,,2200.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.2
,,13880431,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)c1ccccc1Oc1ncccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '12.75', 'le': '0.24', 'lle': '-1.03', 'sei': '7.83'}",CHEMBL2333770,,CHEMBL2333770,5.68,0,http://www.openphacts.org/units/Nanomolar,1958373,=,1,1,=,,IC50,nM,,2100.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.1
,,13880432,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCCCC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '11.84', 'le': '0.22', 'lle': '-1.88', 'sei': '10.63'}",CHEMBL3104624,,CHEMBL3104624,5.70,0,http://www.openphacts.org/units/Nanomolar,1959641,=,1,1,=,,IC50,nM,,2000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.0
,,13880437,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '11.17', 'le': '0.21', 'lle': '-1.59', 'sei': '10.86'}",CHEMBL3104636,,CHEMBL3104636,6.17,0,http://www.openphacts.org/units/Nanomolar,1959653,=,1,1,=,,IC50,nM,,670.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.67
,,13880448,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCCC2(C1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3105200,,CHEMBL3105200,,0,http://www.openphacts.org/units/Nanomolar,1960345,>,1,1,>,,IC50,nM,,40000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,40.0
,,13880449,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ncccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3105198,,CHEMBL3105198,,0,http://www.openphacts.org/units/Nanomolar,1960343,>,1,1,>,,IC50,nM,,40000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,40.0
,,13880450,[],CHEMBL3107674,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccncc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3105197,,CHEMBL3105197,,0,http://www.openphacts.org/units/Nanomolar,1960342,>,1,1,>,,IC50,nM,,40000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,40.0
,,13880451,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)NC(=O)N1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104631,,CHEMBL3104631,,0,http://www.openphacts.org/units/Nanomolar,1959648,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
,,13880457,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CCN(C(=O)OCc3ccccc3)CC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3104625,,CHEMBL3104625,,0,http://www.openphacts.org/units/Nanomolar,1959642,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
,,13880458,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CC2(CC2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103634,,CHEMBL3103634,,0,http://www.openphacts.org/units/Nanomolar,1958384,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
,,13880459,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CN1CCN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103633,,CHEMBL3103633,,0,http://www.openphacts.org/units/Nanomolar,1958383,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
,,13880460,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2ccccc2O1,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103632,,CHEMBL3103632,,0,http://www.openphacts.org/units/Nanomolar,1958382,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
,,13880461,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CCOc2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103631,,CHEMBL3103631,,0,http://www.openphacts.org/units/Nanomolar,1958381,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
,,13880462,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1CCN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103630,,CHEMBL3103630,,0,http://www.openphacts.org/units/Nanomolar,1958380,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
,,13880463,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccccc1N1CCCc2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103629,,CHEMBL3103629,,0,http://www.openphacts.org/units/Nanomolar,1958379,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
,,13880464,[],CHEMBL3107683,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ncccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2ccccc21,,,CHEMBL3102727,J Med Chem,2013,,CHEMBL3103626,,CHEMBL3103626,,0,http://www.openphacts.org/units/Nanomolar,1958375,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
,,14661158,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1nc3ccc(Cl)nc3s1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263056,,CHEMBL3263056,9.92,1,http://www.openphacts.org/units/Nanomolar,2101949,=,1,1,=,,IC50,nM,,0.12,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.12
,,14661159,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccccc3)s1)c1c(O)ccc(C(F)(F)F)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263057,,CHEMBL3263057,9.72,0,http://www.openphacts.org/units/Nanomolar,2101950,=,1,1,=,,IC50,nM,,0.19,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.19
,,14661160,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nc(-c3ccccc3)ns1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263058,,CHEMBL3263058,8.19,0,http://www.openphacts.org/units/Nanomolar,2101951,=,1,1,=,,IC50,nM,,6.4,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,6.4
,,14661161,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccccc3)o1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263059,,CHEMBL3263059,7.31,0,http://www.openphacts.org/units/Nanomolar,2101952,=,1,1,=,,IC50,nM,,49.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,49.0
,Not Determined,14661162,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1cc(-c3ccccc3)on1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263060,,CHEMBL3263060,,0,,2101953,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,,14661163,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nc(-c3ccccc3)cs1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263061,,CHEMBL3263061,7.27,0,http://www.openphacts.org/units/Nanomolar,2101954,=,1,1,=,,IC50,nM,,54.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,54.0
,,14661164,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1ncc(-c3ccccc3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263062,,CHEMBL3263062,8.64,0,http://www.openphacts.org/units/Nanomolar,2101955,=,1,1,=,,IC50,nM,,2.3,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,2.3
,Not Determined,14661165,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(Nc3ccccc3N3CC4(CCN(CC(C)(C)C)CC4)c4c(Cl)ccc(O)c43)nc2)cc1,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263063,,CHEMBL3263063,,0,,2101956,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,14661166,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1ccc(-c3ccccc3)nn1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263064,,CHEMBL3263064,,0,,2101957,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,14661167,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1cnc(-c3ccccc3)cn1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263065,,CHEMBL3263065,,0,,2101958,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,,14661168,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(C(F)(F)F)cc3)s1)c1c(O)ccc(C(F)(F)F)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263066,,CHEMBL3263066,10.10,0,http://www.openphacts.org/units/Nanomolar,2101959,=,1,1,=,,IC50,nM,,0.08,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.08
,,14661169,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(C(C)(C)C)cc3)s1)c1c(O)ccc(C(F)(F)F)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263067,,CHEMBL3263067,9.68,0,http://www.openphacts.org/units/Nanomolar,2101960,=,1,1,=,,IC50,nM,,0.21,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.21
,,14661170,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(C(C)(C)C)cc3)s1)c1c(O)ccc(C#N)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263068,,CHEMBL3263068,9.47,0,http://www.openphacts.org/units/Nanomolar,2101961,=,1,1,=,,IC50,nM,,0.34,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.34
,,14661171,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,COC(=O)c1ccc(O)c2c1C1(CCN(CC(C)(C)C)CC1)CN2c1ccccc1Nc1nnc(-c2ccc(C(C)(C)C)cc2)s1,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263069,,CHEMBL3263069,9.49,0,http://www.openphacts.org/units/Nanomolar,2101962,=,1,1,=,,IC50,nM,,0.32,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.32
,,14661172,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(OC(F)(F)F)cc3)s1)c1c(O)ccc(F)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263070,,CHEMBL3263070,8.57,0,http://www.openphacts.org/units/Nanomolar,2101963,=,1,1,=,,IC50,nM,,2.7,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,2.7
,,14661173,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(OC(F)(F)F)cc3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263071,,CHEMBL3263071,9.20,0,http://www.openphacts.org/units/Nanomolar,2101964,=,1,1,=,,IC50,nM,,0.63,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.63
,,14661174,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccccc3Cl)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263072,,CHEMBL3263072,8.01,0,http://www.openphacts.org/units/Nanomolar,2101965,=,1,1,=,,IC50,nM,,9.8,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,9.8
,,14661175,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cccc(Cl)c3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263073,,CHEMBL3263073,8.44,0,http://www.openphacts.org/units/Nanomolar,2101966,=,1,1,=,,IC50,nM,,3.6,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,3.6
,,14661176,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(Cl)cc3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263074,,CHEMBL3263074,8.80,0,http://www.openphacts.org/units/Nanomolar,2101967,=,1,1,=,,IC50,nM,,1.6,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,1.6
,,14661177,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cnccn3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263075,,CHEMBL3263075,8.82,0,http://www.openphacts.org/units/Nanomolar,2101968,=,1,1,=,,IC50,nM,,1.5,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,1.5
,,14661178,[],CHEMBL3267607,Inhibition of P2Y1 receptor in human washed platelets assessed as decrease in 2-methylthio-ADP-induced calcium signal transduction pathway activation by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2nnc(Nc3ccccc3N3CC4(CCN(CC(C)(C)C)CC4)c4c(Cl)ccc(O)c43)s2)n(C)n1,,,CHEMBL3259700,Bioorg Med Chem Lett,2014,,CHEMBL3263076,,CHEMBL3263076,9.70,0,http://www.openphacts.org/units/Nanomolar,2101969,=,1,1,=,,IC50,nM,,0.2,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.2
,,14726759,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccc(O)cc12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,,CHEMBL3287039,,CHEMBL3287039,,0,http://www.openphacts.org/units/Nanomolar,2114293,>,1,1,>,,IC50,nM,,150.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,150.0
,,14726760,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1cccc(O)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,,CHEMBL3287048,,CHEMBL3287048,,0,http://www.openphacts.org/units/Nanomolar,2114305,>,1,1,>,,IC50,nM,,150.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,150.0
,,14726846,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1nc3ccc(Cl)nc3s1)c1c(O)ccc(Cl)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '16.22', 'le': '0.33', 'lle': '2.04', 'sei': '10.60'}",CHEMBL3263056,,CHEMBL3263056,9.92,0,http://www.openphacts.org/units/Nanomolar,2114296,=,1,1,=,,IC50,nM,,0.12,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.12
,,14726847,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1nc3ccc(Cl)cc3s1)c1c(O)ccc(Cl)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '16.00', 'le': '0.33', 'lle': '1.29', 'sei': '12.10'}",CHEMBL3287040,,CHEMBL3287040,9.77,0,http://www.openphacts.org/units/Nanomolar,2114297,=,1,1,=,,IC50,nM,,0.17,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.17
,,14726848,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1nc3ccc(F)cc3s1)c1c(O)ccc(Cl)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '17.20', 'le': '0.34', 'lle': '2.25', 'sei': '12.66'}",CHEMBL3287049,,CHEMBL3287049,10.22,0,http://www.openphacts.org/units/Nanomolar,2114306,=,1,1,=,,IC50,nM,,0.06,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.06
,,14726849,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1csc(Cl)n1)c1c(O)ccc(Cl)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '18.77', 'le': '0.39', 'lle': '3.19', 'sei': '13.03'}",CHEMBL3287050,,CHEMBL3287050,10.52,0,http://www.openphacts.org/units/Nanomolar,2114307,=,1,1,=,,IC50,nM,,0.03,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.03
,,14726850,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(C(F)(F)F)cc1)c1c(O)ccc(Cl)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '17.20', 'le': '0.34', 'lle': '1.86', 'sei': '14.88'}",CHEMBL3287051,,CHEMBL3287051,10.10,0,http://www.openphacts.org/units/Nanomolar,2114308,=,1,1,=,,IC50,nM,,0.08,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.08
,,14726851,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)c1ccc(O)c2c1C1(CCN(CC(C)(C)C)CC1)CN2c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '15.68', 'le': '0.30', 'lle': '2.57', 'sei': '9.50'}",CHEMBL3287052,,CHEMBL3287052,9.82,0,http://www.openphacts.org/units/Nanomolar,2114309,=,1,1,=,,IC50,nM,,0.15,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.15
,,14726852,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1c(O)ccc(C(F)(F)F)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '15.48', 'le': '0.30', 'lle': '1.36', 'sei': '12.79'}",CHEMBL3287041,,CHEMBL3287041,9.85,0,http://www.openphacts.org/units/Nanomolar,2114298,=,1,1,=,,IC50,nM,,0.14,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.14
,,14726853,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)S(=O)(=O)c1ccc(O)c2c1C1(CCN(CC(C)(C)C)CC1)CN2c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '14.63', 'le': '0.29', 'lle': '3.17', 'sei': '8.64'}",CHEMBL3287042,,CHEMBL3287042,9.89,0,http://www.openphacts.org/units/Nanomolar,2114299,=,1,1,=,,IC50,nM,,0.13,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.13
,,14726854,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1c(O)ccc(C#N)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '17.52', 'le': '0.33', 'lle': '3.06', 'sei': '10.31'}",CHEMBL3287043,,CHEMBL3287043,10.40,0,http://www.openphacts.org/units/Nanomolar,2114300,=,1,1,=,,IC50,nM,,0.04,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.04
,,14726855,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1c(O)ccc(Cl)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '17.24', 'le': '0.34', 'lle': '2.28', 'sei': '13.49'}",CHEMBL3287044,,CHEMBL3287044,10.40,0,http://www.openphacts.org/units/Nanomolar,2114301,=,1,1,=,,IC50,nM,,0.04,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.04
,,14726856,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1c(O)ccc(F)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '16.08', 'le': '0.31', 'lle': '1.82', 'sei': '12.24'}",CHEMBL3287045,,CHEMBL3287045,9.43,0,http://www.openphacts.org/units/Nanomolar,2114302,=,1,1,=,,IC50,nM,,0.37,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.37
,,14726857,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1cc(O)ccc12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '14.66', 'le': '0.28', 'lle': '0.87', 'sei': '10.82'}",CHEMBL3287046,,CHEMBL3287046,8.34,0,http://www.openphacts.org/units/Nanomolar,2114303,=,1,1,=,,IC50,nM,,4.6,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,4.6
,,14726858,[],CHEMBL3292933,Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1c(O)cccc12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '16.95', 'le': '0.32', 'lle': '2.17', 'sei': '12.51'}",CHEMBL3287047,,CHEMBL3287047,9.64,0,http://www.openphacts.org/units/Nanomolar,2114304,=,1,1,=,,IC50,nM,,0.23,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.23
,,15049613,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2nc3ccc(Cl)nc3s2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314287,,CHEMBL3314287,9.85,0,http://www.openphacts.org/units/Nanomolar,2257002,=,1,1,=,,IC50,nM,,0.14,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.14
,,15049614,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314288,,CHEMBL3314288,9.41,0,http://www.openphacts.org/units/Nanomolar,2257003,=,1,1,=,,IC50,nM,,0.39,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.39
,,15049615,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(CC(F)(F)F)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314289,,CHEMBL3314289,8.71,0,http://www.openphacts.org/units/Nanomolar,2257004,=,1,1,=,,IC50,nM,,1.96,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,1.96
,,15049616,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CCOC(=O)C1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314290,,CHEMBL3314290,10.05,0,http://www.openphacts.org/units/Nanomolar,2257005,=,1,1,=,,IC50,nM,,0.09,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.09
,,15049617,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CCOC(=O)C1(C)CN(c2ccccc2NC(=O)Nc2nc3ccc(Cl)nc3s2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314291,,CHEMBL3314291,10.30,0,http://www.openphacts.org/units/Nanomolar,2257006,=,1,1,=,,IC50,nM,,0.05,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.05
,Not Determined,15049618,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(CO)CN(c2ccccc2NC(=O)Nc2nc3ccc(Cl)nc3s2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314292,,CHEMBL3314292,,0,,2257007,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,15049619,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C(=O)O)CN(c2ccccc2NC(=O)Nc2nc3ccc(Cl)nc3s2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314293,,CHEMBL3314293,,0,,2257008,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,Not Determined,15049620,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)C1(C)CN(c2ccccc2NC(=O)Nc2nc3ccc(F)cc3s2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314294,,CHEMBL3314294,,0,,2257009,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,,15049621,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccccc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314295,,CHEMBL3314295,9.43,0,http://www.openphacts.org/units/Nanomolar,2257010,=,1,1,=,,IC50,nM,,0.37,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.37
,,15049622,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccccc3F)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314296,,CHEMBL3314296,9.43,0,http://www.openphacts.org/units/Nanomolar,2257011,=,1,1,=,,IC50,nM,,0.37,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.37
,,15049623,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3cccc(F)c3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314297,,CHEMBL3314297,9.82,0,http://www.openphacts.org/units/Nanomolar,2257012,=,1,1,=,,IC50,nM,,0.15,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.15
,,15049624,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccc(F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314298,,CHEMBL3314298,9.48,0,http://www.openphacts.org/units/Nanomolar,2257013,=,1,1,=,,IC50,nM,,0.33,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.33
,,15049625,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccc(Cl)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314299,,CHEMBL3314299,9.89,0,http://www.openphacts.org/units/Nanomolar,2257014,=,1,1,=,,IC50,nM,,0.13,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.13
,,15049626,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccc(C(F)(F)F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314300,,CHEMBL3314300,8.82,0,http://www.openphacts.org/units/Nanomolar,2257015,=,1,1,=,,IC50,nM,,1.51,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,1.51
,,15049627,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccc(F)cc3F)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314301,,CHEMBL3314301,9.28,0,http://www.openphacts.org/units/Nanomolar,2257016,=,1,1,=,,IC50,nM,,0.52,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.52
,,15049628,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccc(F)c(F)c3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314302,,CHEMBL3314302,8.74,0,http://www.openphacts.org/units/Nanomolar,2257017,=,1,1,=,,IC50,nM,,1.8,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,1.8
,,15049629,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3cc(F)cc(F)c3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314303,,CHEMBL3314303,9.24,0,http://www.openphacts.org/units/Nanomolar,2257018,=,1,1,=,,IC50,nM,,0.57,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.57
,,15049630,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2nc3ccc(Cl)nc3s2)c2c(O)ccc(-c3ccc(F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314304,,CHEMBL3314304,9.89,0,http://www.openphacts.org/units/Nanomolar,2257019,=,1,1,=,,IC50,nM,,0.13,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.13
,,15049631,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2csc(Cl)n2)c2c(O)ccc(-c3ccc(F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314305,,CHEMBL3314305,10.52,0,http://www.openphacts.org/units/Nanomolar,2257020,=,1,1,=,,IC50,nM,,0.03,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.03
,,15049632,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,Cc1nc(NC(=O)Nc2ccccc2N2CC(C)(C)c3c(-c4ccc(F)cc4)ccc(O)c32)cs1,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314306,,CHEMBL3314306,10.10,0,http://www.openphacts.org/units/Nanomolar,2257021,=,1,1,=,,IC50,nM,,0.08,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.08
,,15049633,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)CN1CCCC1c1ccc(NC(=O)Nc2ccccc2N2CC(C)(C)c3c(-c4ccc(F)cc4)ccc(O)c32)cc1,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314307,,CHEMBL3314307,10.70,0,http://www.openphacts.org/units/Nanomolar,2257022,=,1,1,=,,IC50,nM,,0.02,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.02
,,15049634,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCCC1c1ccc(NC(=O)Nc2ccccc2N2CC(C)(C)c3c(-c4ccc(F)cc4)ccc(O)c32)cc1,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314308,,CHEMBL3314308,10.40,0,http://www.openphacts.org/units/Nanomolar,2257023,=,1,1,=,,IC50,nM,,0.04,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.04
,,15049635,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ccc(F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314309,,CHEMBL3314309,9.64,0,http://www.openphacts.org/units/Nanomolar,2257024,=,1,1,=,,IC50,nM,,0.23,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.23
,,15049636,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)c(F)cc(-c3ccc(F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314310,,CHEMBL3314310,9.35,0,http://www.openphacts.org/units/Nanomolar,2257025,=,1,1,=,,IC50,nM,,0.45,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.45
,,15049637,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ccc(Cl)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314311,,CHEMBL3314311,8.97,0,http://www.openphacts.org/units/Nanomolar,2257026,=,1,1,=,,IC50,nM,,1.06,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,1.06
,Not Determined,15049638,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)c(F)cc(-c3ccc(Cl)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314312,,CHEMBL3314312,,0,,2257027,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,,15049639,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ccc(Cl)s3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314313,,CHEMBL3314313,8.64,0,http://www.openphacts.org/units/Nanomolar,2257028,=,1,1,=,,IC50,nM,,2.3,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,2.3
,,15049640,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ccc(C(F)(F)F)cn3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314314,,CHEMBL3314314,9.24,0,http://www.openphacts.org/units/Nanomolar,2257029,=,1,1,=,,IC50,nM,,0.57,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.57
,,15049641,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ccc(C(F)(F)F)nc3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314315,,CHEMBL3314315,9.29,0,http://www.openphacts.org/units/Nanomolar,2257030,=,1,1,=,,IC50,nM,,0.51,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.51
,,15049642,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3cc(F)nc(F)c3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314316,,CHEMBL3314316,9.33,0,http://www.openphacts.org/units/Nanomolar,2257031,=,1,1,=,,IC50,nM,,0.47,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.47
,,15049643,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ncc(F)cn3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314317,,CHEMBL3314317,9.52,0,http://www.openphacts.org/units/Nanomolar,2257032,=,1,1,=,,IC50,nM,,0.3,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.3
,Not Determined,15049644,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3cnc(Cl)cn3)c21,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314318,,CHEMBL3314318,,0,,2257033,,1,0,,,IC50,,,,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,,,,
,,15049645,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1nc3ccc(Cl)nc3s1)c1c(O)ccc(Cl)c12,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3263056,,CHEMBL3263056,9.92,1,http://www.openphacts.org/units/Nanomolar,2257034,=,1,1,=,,IC50,nM,,0.12,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.12
,,15049646,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1c(O)cc(F)c(-c3ccc(Cl)cc3)c12,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314319,,CHEMBL3314319,9.80,0,http://www.openphacts.org/units/Nanomolar,2257035,=,1,1,=,,IC50,nM,,0.16,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.16
,,15049647,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1c(O)cc(F)c(-c3ccc(F)cc3)c12,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314320,,CHEMBL3314320,10.05,0,http://www.openphacts.org/units/Nanomolar,2257036,=,1,1,=,,IC50,nM,,0.09,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.09
,,15049648,[],CHEMBL3365972,Antagonist activity at P2Y1 receptor in washed human platelets assessed as 1 uM 2-methylthio-ADP-induced calcium flux by FLIPR assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1nc3ccc(Cl)nc3s1)c1c(O)cc(F)c(-c3ccc(F)cc3)c12,,,CHEMBL3352472,J Med Chem,2014,,CHEMBL3314321,,CHEMBL3314321,9.92,0,http://www.openphacts.org/units/Nanomolar,2257037,=,1,1,=,,IC50,nM,,0.12,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,0.12
,,15049649,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2nc3ccc(Cl)nc3s2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.70', 'le': '0.24', 'lle': '-0.93', 'sei': '6.48'}",CHEMBL3314287,,CHEMBL3314287,5.85,0,http://www.openphacts.org/units/Nanomolar,2257002,=,1,1,=,,IC50,nM,,1400.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.4
,,15049650,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '12.32', 'le': '0.24', 'lle': '-0.96', 'sei': '8.21'}",CHEMBL3314288,,CHEMBL3314288,6.06,0,http://www.openphacts.org/units/Nanomolar,2257003,=,1,1,=,,IC50,nM,,870.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.87
,,15049651,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(CC(F)(F)F)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '9.89', 'le': '0.20', 'lle': '-2.41', 'sei': '7.50'}",CHEMBL3314289,,CHEMBL3314289,5.54,0,http://www.openphacts.org/units/Nanomolar,2257004,=,1,1,=,,IC50,nM,,2900.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.9
,,15049652,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CCOC(=O)C1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '10.02', 'le': '0.20', 'lle': '-1.05', 'sei': '5.50'}",CHEMBL3314290,,CHEMBL3314290,5.51,0,http://www.openphacts.org/units/Nanomolar,2257005,=,1,1,=,,IC50,nM,,3100.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,3.1
,,15049653,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CCOC(=O)C1(C)CN(c2ccccc2NC(=O)Nc2nc3ccc(Cl)nc3s2)c2c(O)ccc(Cl)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.13', 'le': '0.23', 'lle': '-0.11', 'sei': '5.33'}",CHEMBL3314291,,CHEMBL3314291,6.21,0,http://www.openphacts.org/units/Nanomolar,2257006,=,1,1,=,,IC50,nM,,610.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.61
,,15049654,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccccc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '12.64', 'le': '0.24', 'lle': '-1.29', 'sei': '9.14'}",CHEMBL3314295,,CHEMBL3314295,6.75,0,http://www.openphacts.org/units/Nanomolar,2257010,=,1,1,=,,IC50,nM,,180.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.18
,,15049655,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccccc3F)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '12.87', 'le': '0.24', 'lle': '-1.07', 'sei': '9.61'}",CHEMBL3314296,,CHEMBL3314296,7.10,0,http://www.openphacts.org/units/Nanomolar,2257011,=,1,1,=,,IC50,nM,,80.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.08
,,15049656,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3cccc(F)c3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '12.00', 'le': '0.23', 'lle': '-1.55', 'sei': '8.97'}",CHEMBL3314297,,CHEMBL3314297,6.62,0,http://www.openphacts.org/units/Nanomolar,2257012,=,1,1,=,,IC50,nM,,240.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.24
,,15049657,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccc(F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '12.32', 'le': '0.23', 'lle': '-1.37', 'sei': '9.20'}",CHEMBL3314298,,CHEMBL3314298,6.80,0,http://www.openphacts.org/units/Nanomolar,2257013,=,1,1,=,,IC50,nM,,160.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.16
,,15049658,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccc(Cl)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.76', 'le': '0.23', 'lle': '-2.00', 'sei': '9.04'}",CHEMBL3314299,,CHEMBL3314299,6.68,0,http://www.openphacts.org/units/Nanomolar,2257014,=,1,1,=,,IC50,nM,,210.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.21
,,15049659,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccc(C(F)(F)F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.04', 'le': '0.21', 'lle': '-2.41', 'sei': '8.99'}",CHEMBL3314300,,CHEMBL3314300,6.64,0,http://www.openphacts.org/units/Nanomolar,2257015,=,1,1,=,,IC50,nM,,230.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.23
,,15049660,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccc(F)cc3F)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.93', 'le': '0.23', 'lle': '-1.51', 'sei': '9.20'}",CHEMBL3314301,,CHEMBL3314301,6.80,0,http://www.openphacts.org/units/Nanomolar,2257016,=,1,1,=,,IC50,nM,,160.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.16
,,15049661,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3ccc(F)c(F)c3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.23', 'le': '0.21', 'lle': '-1.91', 'sei': '8.67'}",CHEMBL3314302,,CHEMBL3314302,6.40,0,http://www.openphacts.org/units/Nanomolar,2257017,=,1,1,=,,IC50,nM,,400.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.4
,,15049662,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)ccc(-c3cc(F)cc(F)c3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.84', 'le': '0.22', 'lle': '-1.57', 'sei': '9.14'}",CHEMBL3314303,,CHEMBL3314303,6.75,0,http://www.openphacts.org/units/Nanomolar,2257018,=,1,1,=,,IC50,nM,,180.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.18
,,15049663,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2nc3ccc(Cl)nc3s2)c2c(O)ccc(-c3ccc(F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.85', 'le': '0.23', 'lle': '-1.29', 'sei': '7.34'}",CHEMBL3314304,,CHEMBL3314304,6.64,0,http://www.openphacts.org/units/Nanomolar,2257019,=,1,1,=,,IC50,nM,,230.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.23
,,15049664,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2csc(Cl)n2)c2c(O)ccc(-c3ccc(F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '13.84', 'le': '0.27', 'lle': '-0.33', 'sei': '9.09'}",CHEMBL3314305,,CHEMBL3314305,7.05,0,http://www.openphacts.org/units/Nanomolar,2257020,=,1,1,=,,IC50,nM,,90.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.09
,,15049665,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,Cc1nc(NC(=O)Nc2ccccc2N2CC(C)(C)c3c(-c4ccc(F)cc4)ccc(O)c32)cs1,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '13.03', 'le': '0.25', 'lle': '-0.67', 'sei': '8.22'}",CHEMBL3314306,,CHEMBL3314306,6.37,0,http://www.openphacts.org/units/Nanomolar,2257021,=,1,1,=,,IC50,nM,,430.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.43
,,15049666,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)CN1CCCC1c1ccc(NC(=O)Nc2ccccc2N2CC(C)(C)c3c(-c4ccc(F)cc4)ccc(O)c32)cc1,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '12.32', 'le': '0.23', 'lle': '-1.76', 'sei': '10.76'}",CHEMBL3314307,,CHEMBL3314307,7.30,0,http://www.openphacts.org/units/Nanomolar,2257022,=,1,1,=,,IC50,nM,,50.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.05
,,15049667,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCCC1c1ccc(NC(=O)Nc2ccccc2N2CC(C)(C)c3c(-c4ccc(F)cc4)ccc(O)c32)cc1,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.61', 'le': '0.21', 'lle': '-2.40', 'sei': '10.39'}",CHEMBL3314308,,CHEMBL3314308,7.05,0,http://www.openphacts.org/units/Nanomolar,2257023,=,1,1,=,,IC50,nM,,90.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.09
,,15049668,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ccc(F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.80', 'le': '0.22', 'lle': '-1.59', 'sei': '9.10'}",CHEMBL3314309,,CHEMBL3314309,6.72,0,http://www.openphacts.org/units/Nanomolar,2257024,=,1,1,=,,IC50,nM,,190.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.19
,,15049669,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)c(F)cc(-c3ccc(F)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.25', 'le': '0.21', 'lle': '-1.90', 'sei': '8.68'}",CHEMBL3314310,,CHEMBL3314310,6.41,0,http://www.openphacts.org/units/Nanomolar,2257025,=,1,1,=,,IC50,nM,,390.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.39
,,15049670,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ccc(Cl)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.30', 'le': '0.22', 'lle': '-2.20', 'sei': '8.97'}",CHEMBL3314311,,CHEMBL3314311,6.62,0,http://www.openphacts.org/units/Nanomolar,2257026,=,1,1,=,,IC50,nM,,240.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.24
,,15049671,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)c(F)cc(-c3ccc(Cl)cc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.13', 'le': '0.22', 'lle': '-2.30', 'sei': '8.83'}",CHEMBL3314312,,CHEMBL3314312,6.52,0,http://www.openphacts.org/units/Nanomolar,2257027,=,1,1,=,,IC50,nM,,300.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.3
,,15049672,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ccc(Cl)s3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.63', 'le': '0.24', 'lle': '-2.00', 'sei': '9.33'}",CHEMBL3314313,,CHEMBL3314313,6.89,0,http://www.openphacts.org/units/Nanomolar,2257028,=,1,1,=,,IC50,nM,,130.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.13
,,15049673,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ccc(C(F)(F)F)cn3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.21', 'le': '0.22', 'lle': '-1.62', 'sei': '8.02'}",CHEMBL3314314,,CHEMBL3314314,6.96,0,http://www.openphacts.org/units/Nanomolar,2257029,=,1,1,=,,IC50,nM,,110.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.11
,,15049674,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ccc(C(F)(F)F)nc3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.00', 'le': '0.21', 'lle': '-1.76', 'sei': '7.87'}",CHEMBL3314315,,CHEMBL3314315,6.82,0,http://www.openphacts.org/units/Nanomolar,2257030,=,1,1,=,,IC50,nM,,150.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.15
,,15049675,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3cc(F)nc(F)c3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.55', 'le': '0.22', 'lle': '-1.04', 'sei': '7.84'}",CHEMBL3314316,,CHEMBL3314316,6.80,0,http://www.openphacts.org/units/Nanomolar,2257031,=,1,1,=,,IC50,nM,,160.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.16
,,15049676,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3ncc(F)cn3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '10.54', 'le': '0.20', 'lle': '-1.08', 'sei': '6.05'}",CHEMBL3314317,,CHEMBL3314317,6.02,0,http://www.openphacts.org/units/Nanomolar,2257032,=,1,1,=,,IC50,nM,,950.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.95
,,15049677,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC1(C)CN(c2ccccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)c2c(O)cc(F)c(-c3cnc(Cl)cn3)c21,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.20', 'le': '0.22', 'lle': '-1.02', 'sei': '6.61'}",CHEMBL3314318,,CHEMBL3314318,6.58,0,http://www.openphacts.org/units/Nanomolar,2257033,=,1,1,=,,IC50,nM,,260.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.26
,,15049678,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1nc3ccc(Cl)nc3s1)c1c(O)ccc(Cl)c12,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '11.26', 'le': '0.23', 'lle': '-0.99', 'sei': '7.36'}",CHEMBL3263056,,CHEMBL3263056,6.89,0,http://www.openphacts.org/units/Nanomolar,2257034,=,1,1,=,,IC50,nM,,130.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.13
,,15049679,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1c(O)cc(F)c(-c3ccc(Cl)cc3)c12,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '9.61', 'le': '0.19', 'lle': '-3.23', 'sei': '8.69'}",CHEMBL3314319,,CHEMBL3314319,6.70,0,http://www.openphacts.org/units/Nanomolar,2257035,=,1,1,=,,IC50,nM,,200.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.2
,,15049680,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1c(O)cc(F)c(-c3ccc(F)cc3)c12,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '10.07', 'le': '0.19', 'lle': '-2.56', 'sei': '8.89'}",CHEMBL3314320,,CHEMBL3314320,6.85,0,http://www.openphacts.org/units/Nanomolar,2257036,=,1,1,=,,IC50,nM,,140.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.14
,,15049681,[],CHEMBL3365973,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,B,,,BAO_0000190,BAO_0000366,cell-free format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1nc3ccc(Cl)nc3s1)c1c(O)cc(F)c(-c3ccc(F)cc3)c12,,,CHEMBL3352472,J Med Chem,2014,"{'bei': '9.79', 'le': '0.19', 'lle': '-2.43', 'sei': '7.20'}",CHEMBL3314321,,CHEMBL3314321,6.75,0,http://www.openphacts.org/units/Nanomolar,2257037,=,1,1,=,,IC50,nM,,180.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.18
,,16419537,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3747288,,CHEMBL3747864,4.99,0,http://www.openphacts.org/units/Nanomolar,2741404,=,1,1,=,,IC50,nM,,10200.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.2
,,16419538,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3745979,,CHEMBL3747865,5.31,0,http://www.openphacts.org/units/Nanomolar,2741405,=,1,1,=,,IC50,nM,,4900.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,4.9
,,16419539,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([S-])OP(=O)([O-])OP(=O)([O-])OP(=O)([S-])OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746558,,CHEMBL3747866,6.80,0,http://www.openphacts.org/units/Nanomolar,2741406,=,1,1,=,,IC50,nM,,160.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.16
,,16419540,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([O-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([O-])OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746620,,CHEMBL3747867,4.54,0,http://www.openphacts.org/units/Nanomolar,2741407,=,1,1,=,,IC50,nM,,29000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,29.0
,,16419541,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3747385,,CHEMBL3747868,5.67,0,http://www.openphacts.org/units/Nanomolar,2741408,=,1,1,=,,IC50,nM,,2150.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.15
,,16419542,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3747704,,CHEMBL3747869,5.02,0,http://www.openphacts.org/units/Nanomolar,2741409,=,1,1,=,,IC50,nM,,9600.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,9.6
,,16419543,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3745863,,CHEMBL3747870,5.20,0,http://www.openphacts.org/units/Nanomolar,2741410,=,1,1,=,,IC50,nM,,6300.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,6.3
,,16419544,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746192,,CHEMBL3747871,5.28,0,http://www.openphacts.org/units/Nanomolar,2741411,=,1,1,=,,IC50,nM,,5200.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,5.2
,,16419545,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746188,,CHEMBL3747872,5.38,0,http://www.openphacts.org/units/Nanomolar,2741412,=,1,1,=,,IC50,nM,,4210.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,4.21
,,16419546,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746502,,CHEMBL3747873,5.13,0,http://www.openphacts.org/units/Nanomolar,2741413,=,1,1,=,,IC50,nM,,7370.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,7.37
,,16419547,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746598,,CHEMBL3747874,5.65,0,http://www.openphacts.org/units/Nanomolar,2741414,=,1,1,=,,IC50,nM,,2240.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.24
,,16419548,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746901,,CHEMBL3747875,5.58,0,http://www.openphacts.org/units/Nanomolar,2741415,=,1,1,=,,IC50,nM,,2650.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.65
,,16419549,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CNc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]2O[C@@H](n3cnc4c(NC)ncnc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746177,,CHEMBL3747876,5.71,0,http://www.openphacts.org/units/Nanomolar,2741416,=,1,1,=,,IC50,nM,,1970.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.97
,,16419550,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CCCNc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]2O[C@@H](n3cnc4c(NCCC)ncnc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746451,,CHEMBL3747877,5.06,0,http://www.openphacts.org/units/Nanomolar,2741417,=,1,1,=,,IC50,nM,,8800.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,8.8
,,16419551,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746852,,CHEMBL3747878,6.44,0,http://www.openphacts.org/units/Nanomolar,2741418,=,1,1,=,,IC50,nM,,360.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.36
,,16419552,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+].[Na+],,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL3746312,,CHEMBL3747879,5.99,0,http://www.openphacts.org/units/Nanomolar,2741419,=,1,1,=,,IC50,nM,,1020.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.02
,,16419553,[],CHEMBL3748124,Antagonist activity at human platelet P2Y1 receptor assessed as inhibition of ADP-induced increase in cytosolic calcium level by FLUO-4 staining based flow cytometric analysis,F,,,BAO_0000190,BAO_0000019,assay format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL3745686,Eur J Med Chem,2016,,CHEMBL129841,,CHEMBL129841,5.65,0,http://www.openphacts.org/units/Nanomolar,2741420,=,1,1,=,,IC50,nM,,2250.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.25
,323755,17702792,[],CHEMBL3887217,"Binding Assay: A membrane binding assay was used to identify inhibitors of [33P] 2MeS- ADP binding to cloned human P2Y1 receptors. The cDNA clone for human P2Yi was obtained from Incyte Pharmaceuticals and its sequence confirmed by established techniques (for a compendium of techniques used see Ausubel, F. et al. Current Protocols in Molecular Biology, John Wiley and Sons, NY, NY (1995)). The essential coding sequences were subcloned into pCDNA 3.1 (Invitrogen) to produce a P2Y1 expression construct. This construct was then transfected into the human embryonic kidney cell line HEK-293 and stable transfectants selected in GENETICIN (G418 sulfate; Life Technologies). Several lines were screened for binding activity and one (HEK293 #49) selected for further characterization. Membranes were prepared by growing HEK293 #49 in 150 mm dishes in DMEM/10% FBS in the presence of lmg/ml G418 until cells were 80-90% confluent. Plates were then washed with cold (4 C) D-PBS twice.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)CN1CCC2(CC1)CCN(c1ccccc1Nc1nc3ccc(C(C)(C)C)cc3[nH]1)c1ccccc12,,,CHEMBL3886218,,2015,"{'bei': '12.29', 'le': '0.22', 'lle': '-1.94', 'sei': '13.96'}",CHEMBL3942314,,CHEMBL3942314,6.59,0,http://www.openphacts.org/units/Nanomolar,2836923,=,37,1,=,,IC50,nM,,258.8,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,258.8
,323756,17702793,[],CHEMBL3887217,"Binding Assay: A membrane binding assay was used to identify inhibitors of [33P] 2MeS- ADP binding to cloned human P2Y1 receptors. The cDNA clone for human P2Yi was obtained from Incyte Pharmaceuticals and its sequence confirmed by established techniques (for a compendium of techniques used see Ausubel, F. et al. Current Protocols in Molecular Biology, John Wiley and Sons, NY, NY (1995)). The essential coding sequences were subcloned into pCDNA 3.1 (Invitrogen) to produce a P2Y1 expression construct. This construct was then transfected into the human embryonic kidney cell line HEK-293 and stable transfectants selected in GENETICIN (G418 sulfate; Life Technologies). Several lines were screened for binding activity and one (HEK293 #49) selected for further characterization. Membranes were prepared by growing HEK293 #49 in 150 mm dishes in DMEM/10% FBS in the presence of lmg/ml G418 until cells were 80-90% confluent. Plates were then washed with cold (4 C) D-PBS twice.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1sc(Nc2ccccc2N2CC3(CCN(CC(C)(C)C)CC3)c3ccccc32)nc1C(F)(F)F,,,CHEMBL3886218,,2015,"{'bei': '14.32', 'le': '0.28', 'lle': '0.59', 'sei': '14.21'}",CHEMBL3904405,,CHEMBL3904405,8.20,0,http://www.openphacts.org/units/Nanomolar,2836924,=,37,1,=,,IC50,nM,,6.3,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,6.3
,323757,17702794,[],CHEMBL3887217,"Binding Assay: A membrane binding assay was used to identify inhibitors of [33P] 2MeS- ADP binding to cloned human P2Y1 receptors. The cDNA clone for human P2Yi was obtained from Incyte Pharmaceuticals and its sequence confirmed by established techniques (for a compendium of techniques used see Ausubel, F. et al. Current Protocols in Molecular Biology, John Wiley and Sons, NY, NY (1995)). The essential coding sequences were subcloned into pCDNA 3.1 (Invitrogen) to produce a P2Y1 expression construct. This construct was then transfected into the human embryonic kidney cell line HEK-293 and stable transfectants selected in GENETICIN (G418 sulfate; Life Technologies). Several lines were screened for binding activity and one (HEK293 #49) selected for further characterization. Membranes were prepared by growing HEK293 #49 in 150 mm dishes in DMEM/10% FBS in the presence of lmg/ml G418 until cells were 80-90% confluent. Plates were then washed with cold (4 C) D-PBS twice.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1sc(Nc2ccccc2N2CC3(CCN(CC(C)(C)C)CC3)c3ccccc32)nc1C,,,CHEMBL3886218,,2015,"{'bei': '15.35', 'le': '0.29', 'lle': '1.23', 'sei': '13.42'}",CHEMBL3915408,,CHEMBL3915408,7.75,0,http://www.openphacts.org/units/Nanomolar,2836925,=,37,1,=,,IC50,nM,,18.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,18.0
,323758,17702795,[],CHEMBL3887217,"Binding Assay: A membrane binding assay was used to identify inhibitors of [33P] 2MeS- ADP binding to cloned human P2Y1 receptors. The cDNA clone for human P2Yi was obtained from Incyte Pharmaceuticals and its sequence confirmed by established techniques (for a compendium of techniques used see Ausubel, F. et al. Current Protocols in Molecular Biology, John Wiley and Sons, NY, NY (1995)). The essential coding sequences were subcloned into pCDNA 3.1 (Invitrogen) to produce a P2Y1 expression construct. This construct was then transfected into the human embryonic kidney cell line HEK-293 and stable transfectants selected in GENETICIN (G418 sulfate; Life Technologies). Several lines were screened for binding activity and one (HEK293 #49) selected for further characterization. Membranes were prepared by growing HEK293 #49 in 150 mm dishes in DMEM/10% FBS in the presence of lmg/ml G418 until cells were 80-90% confluent. Plates were then washed with cold (4 C) D-PBS twice.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nc(C(F)(F)F)c(-c3ccccc3)s1)c1ccccc12,,,CHEMBL3886218,,2015,"{'bei': '14.05', 'le': '0.27', 'lle': '-1.00', 'sei': '25.80'}",CHEMBL3943381,,CHEMBL3943381,8.10,0,http://www.openphacts.org/units/Nanomolar,2836926,=,37,1,=,,IC50,nM,,7.9,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,7.9
,323759,17702796,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccccc3)s1)c1c(O)ccc(C(F)(F)F)c12,,,CHEMBL3886218,,2015,"{'bei': '13.47', 'le': '0.26', 'lle': '-0.20', 'sei': '12.40'}",CHEMBL3263057,,CHEMBL3263057,8.00,0,http://www.openphacts.org/units/Nanomolar,2836927,=,37,1,=,,IC50,nM,,10.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,10.0
,323760,17702797,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(C(C)(C)C)cc3)s1)c1c(O)ccc(C(F)(F)F)c12,,,CHEMBL3886218,,2015,"{'bei': '11.67', 'le': '0.23', 'lle': '-1.91', 'sei': '11.76'}",CHEMBL3263067,,CHEMBL3263067,7.58,0,http://www.openphacts.org/units/Nanomolar,2836928,=,37,1,=,,IC50,nM,,26.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,26.0
,323761,17702798,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(C(F)(F)F)cc3)s1)c1c(O)ccc(C(F)(F)F)c12,,,CHEMBL3886218,,2015,"{'bei': '11.78', 'le': '0.23', 'lle': '-1.42', 'sei': '12.08'}",CHEMBL3263066,,CHEMBL3263066,7.80,0,http://www.openphacts.org/units/Nanomolar,2836929,=,37,1,=,,IC50,nM,,16.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,16.0
,323762,17702799,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(F)cc3)s1)c1c(O)ccc(C(F)(F)F)c12,,,CHEMBL3886218,,2015,"{'bei': '12.79', 'le': '0.25', 'lle': '-0.52', 'sei': '12.13'}",CHEMBL3893716,,CHEMBL3893716,7.82,0,http://www.openphacts.org/units/Nanomolar,2836930,=,37,1,=,,IC50,nM,,15.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,15.0
,323763,17702800,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cccc(F)c3)s1)c1c(O)ccc(C(F)(F)F)c12,,,CHEMBL3886218,,2015,"{'bei': '12.95', 'le': '0.25', 'lle': '-0.42', 'sei': '12.28'}",CHEMBL3928274,,CHEMBL3928274,7.92,0,http://www.openphacts.org/units/Nanomolar,2836931,=,37,1,=,,IC50,nM,,12.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,12.0
,323764,17702801,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccccn3)s1)c1c(O)ccc(C(F)(F)F)c12,,,CHEMBL3886218,,2015,"{'bei': '13.38', 'le': '0.26', 'lle': '0.36', 'sei': '10.28'}",CHEMBL3900332,,CHEMBL3900332,7.96,0,http://www.openphacts.org/units/Nanomolar,2836932,=,37,1,=,,IC50,nM,,11.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,11.0
,323765,17702802,[],CHEMBL3887217,"Binding Assay: A membrane binding assay was used to identify inhibitors of [33P] 2MeS- ADP binding to cloned human P2Y1 receptors. The cDNA clone for human P2Yi was obtained from Incyte Pharmaceuticals and its sequence confirmed by established techniques (for a compendium of techniques used see Ausubel, F. et al. Current Protocols in Molecular Biology, John Wiley and Sons, NY, NY (1995)). The essential coding sequences were subcloned into pCDNA 3.1 (Invitrogen) to produce a P2Y1 expression construct. This construct was then transfected into the human embryonic kidney cell line HEK-293 and stable transfectants selected in GENETICIN (G418 sulfate; Life Technologies). Several lines were screened for binding activity and one (HEK293 #49) selected for further characterization. Membranes were prepared by growing HEK293 #49 in 150 mm dishes in DMEM/10% FBS in the presence of lmg/ml G418 until cells were 80-90% confluent. Plates were then washed with cold (4 C) D-PBS twice.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(C(F)(F)F)cc3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '13.50', 'le': '0.27', 'lle': '-0.38', 'sei': '13.15'}",CHEMBL3934351,,CHEMBL3934351,8.48,0,http://www.openphacts.org/units/Nanomolar,2836933,=,37,1,=,,IC50,nM,,3.3,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,3.3
,323766,17702803,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(C(F)(F)F)cn3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '12.96', 'le': '0.26', 'lle': '-0.10', 'sei': '10.53'}",CHEMBL3896467,,CHEMBL3896467,8.15,0,http://www.openphacts.org/units/Nanomolar,2836934,=,37,1,=,,IC50,nM,,7.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,7.0
,323767,17702804,[],CHEMBL3887217,"Binding Assay: A membrane binding assay was used to identify inhibitors of [33P] 2MeS- ADP binding to cloned human P2Y1 receptors. The cDNA clone for human P2Yi was obtained from Incyte Pharmaceuticals and its sequence confirmed by established techniques (for a compendium of techniques used see Ausubel, F. et al. Current Protocols in Molecular Biology, John Wiley and Sons, NY, NY (1995)). The essential coding sequences were subcloned into pCDNA 3.1 (Invitrogen) to produce a P2Y1 expression construct. This construct was then transfected into the human embryonic kidney cell line HEK-293 and stable transfectants selected in GENETICIN (G418 sulfate; Life Technologies). Several lines were screened for binding activity and one (HEK293 #49) selected for further characterization. Membranes were prepared by growing HEK293 #49 in 150 mm dishes in DMEM/10% FBS in the presence of lmg/ml G418 until cells were 80-90% confluent. Plates were then washed with cold (4 C) D-PBS twice.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cccnc3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '13.57', 'le': '0.27', 'lle': '0.38', 'sei': '9.84'}",CHEMBL3928907,,CHEMBL3928907,7.61,0,http://www.openphacts.org/units/Nanomolar,2836935,=,37,1,=,,IC50,nM,,24.3,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,24.3
,323768,17702805,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccncc3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '13.18', 'le': '0.26', 'lle': '0.17', 'sei': '9.55'}",CHEMBL3956460,,CHEMBL3956460,7.40,0,http://www.openphacts.org/units/Nanomolar,2836936,=,37,1,=,,IC50,nM,,40.2,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,40.2
,323769,17702806,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1ncc(-c3ccccc3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '13.94', 'le': '0.27', 'lle': '-0.64', 'sei': '15.10'}",CHEMBL3263062,,CHEMBL3263062,7.80,0,http://www.openphacts.org/units/Nanomolar,2836937,=,37,1,=,,IC50,nM,,16.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,16.0
,323770,17702807,[],CHEMBL3887217,"Binding Assay: A membrane binding assay was used to identify inhibitors of [33P] 2MeS- ADP binding to cloned human P2Y1 receptors. The cDNA clone for human P2Yi was obtained from Incyte Pharmaceuticals and its sequence confirmed by established techniques (for a compendium of techniques used see Ausubel, F. et al. Current Protocols in Molecular Biology, John Wiley and Sons, NY, NY (1995)). The essential coding sequences were subcloned into pCDNA 3.1 (Invitrogen) to produce a P2Y1 expression construct. This construct was then transfected into the human embryonic kidney cell line HEK-293 and stable transfectants selected in GENETICIN (G418 sulfate; Life Technologies). Several lines were screened for binding activity and one (HEK293 #49) selected for further characterization. Membranes were prepared by growing HEK293 #49 in 150 mm dishes in DMEM/10% FBS in the presence of lmg/ml G418 until cells were 80-90% confluent. Plates were then washed with cold (4 C) D-PBS twice.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cnccn3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '14.56', 'le': '0.29', 'lle': '1.56', 'sei': '9.07'}",CHEMBL3263075,,CHEMBL3263075,8.19,0,http://www.openphacts.org/units/Nanomolar,2836938,=,37,1,=,,IC50,nM,,6.5,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,6.5
,323771,17702808,[],CHEMBL3887217,"Binding Assay: A membrane binding assay was used to identify inhibitors of [33P] 2MeS- ADP binding to cloned human P2Y1 receptors. The cDNA clone for human P2Yi was obtained from Incyte Pharmaceuticals and its sequence confirmed by established techniques (for a compendium of techniques used see Ausubel, F. et al. Current Protocols in Molecular Biology, John Wiley and Sons, NY, NY (1995)). The essential coding sequences were subcloned into pCDNA 3.1 (Invitrogen) to produce a P2Y1 expression construct. This construct was then transfected into the human embryonic kidney cell line HEK-293 and stable transfectants selected in GENETICIN (G418 sulfate; Life Technologies). Several lines were screened for binding activity and one (HEK293 #49) selected for further characterization. Membranes were prepared by growing HEK293 #49 in 150 mm dishes in DMEM/10% FBS in the presence of lmg/ml G418 until cells were 80-90% confluent. Plates were then washed with cold (4 C) D-PBS twice.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2nnc(Nc3ccccc3N3CC4(CCN(CC(C)(C)C)CC4)c4c(Cl)ccc(O)c43)s2)n(C)n1,,,CHEMBL3886218,,2015,"{'bei': '14.15', 'le': '0.28', 'lle': '1.30', 'sei': '9.93'}",CHEMBL3263076,,CHEMBL3263076,8.18,0,http://www.openphacts.org/units/Nanomolar,2836939,=,37,1,=,,IC50,nM,,6.6,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,6.6
,323772,17702809,[],CHEMBL3887217,"Binding Assay: A membrane binding assay was used to identify inhibitors of [33P] 2MeS- ADP binding to cloned human P2Y1 receptors. The cDNA clone for human P2Yi was obtained from Incyte Pharmaceuticals and its sequence confirmed by established techniques (for a compendium of techniques used see Ausubel, F. et al. Current Protocols in Molecular Biology, John Wiley and Sons, NY, NY (1995)). The essential coding sequences were subcloned into pCDNA 3.1 (Invitrogen) to produce a P2Y1 expression construct. This construct was then transfected into the human embryonic kidney cell line HEK-293 and stable transfectants selected in GENETICIN (G418 sulfate; Life Technologies). Several lines were screened for binding activity and one (HEK293 #49) selected for further characterization. Membranes were prepared by growing HEK293 #49 in 150 mm dishes in DMEM/10% FBS in the presence of lmg/ml G418 until cells were 80-90% confluent. Plates were then washed with cold (4 C) D-PBS twice.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(C3CCOCC3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '11.98', 'le': '0.24', 'lle': '-0.26', 'sei': '9.23'}",CHEMBL3984201,,CHEMBL3984201,6.81,0,http://www.openphacts.org/units/Nanomolar,2836940,=,37,1,=,,IC50,nM,,155.4,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,155.4
,323773,17702810,[],CHEMBL3887217,"Binding Assay: A membrane binding assay was used to identify inhibitors of [33P] 2MeS- ADP binding to cloned human P2Y1 receptors. The cDNA clone for human P2Yi was obtained from Incyte Pharmaceuticals and its sequence confirmed by established techniques (for a compendium of techniques used see Ausubel, F. et al. Current Protocols in Molecular Biology, John Wiley and Sons, NY, NY (1995)). The essential coding sequences were subcloned into pCDNA 3.1 (Invitrogen) to produce a P2Y1 expression construct. This construct was then transfected into the human embryonic kidney cell line HEK-293 and stable transfectants selected in GENETICIN (G418 sulfate; Life Technologies). Several lines were screened for binding activity and one (HEK293 #49) selected for further characterization. Membranes were prepared by growing HEK293 #49 in 150 mm dishes in DMEM/10% FBS in the presence of lmg/ml G418 until cells were 80-90% confluent. Plates were then washed with cold (4 C) D-PBS twice.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(C(F)(F)F)nc3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '13.10', 'le': '0.26', 'lle': '-0.01', 'sei': '10.65'}",CHEMBL3910967,,CHEMBL3910967,8.24,0,http://www.openphacts.org/units/Nanomolar,2836941,=,37,1,=,,IC50,nM,,5.7,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,5.7
,323774,17702811,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cnc4ccccc4n3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '11.73', 'le': '0.23', 'lle': '-0.60', 'sei': '7.95'}",CHEMBL3972991,,CHEMBL3972991,7.18,0,http://www.openphacts.org/units/Nanomolar,2836942,=,37,1,=,,IC50,nM,,66.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,66.0
,323775,17702812,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)c1nnc(Nc2ccccc2N2CC3(CCN(CC(C)(C)C)CC3)c3c(Cl)ccc(O)c32)s1,,,CHEMBL3886218,,2015,"{'bei': '13.50', 'le': '0.27', 'lle': '1.36', 'sei': '8.06'}",CHEMBL3901946,,CHEMBL3901946,7.32,0,http://www.openphacts.org/units/Nanomolar,2836943,=,37,1,=,,IC50,nM,,48.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,48.0
,323776,17702813,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1nc(C(C)(C)C)cc1-c1nnc(Nc2ccccc2N2CC3(CCN(CC(C)(C)C)CC3)c3c(Cl)ccc(O)c32)s1,,,CHEMBL3886218,,2015,"{'bei': '12.06', 'le': '0.24', 'lle': '-0.39', 'sei': '9.09'}",CHEMBL3898478,,CHEMBL3898478,7.48,0,http://www.openphacts.org/units/Nanomolar,2836944,=,37,1,=,,IC50,nM,,33.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,33.0
,323777,17702814,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccccc3Cl)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '12.70', 'le': '0.26', 'lle': '-0.94', 'sei': '11.71'}",CHEMBL3263072,,CHEMBL3263072,7.55,0,http://www.openphacts.org/units/Nanomolar,2836945,=,37,1,=,,IC50,nM,,28.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,28.0
,323778,17702815,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cccc(Cl)c3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '13.11', 'le': '0.27', 'lle': '-0.69', 'sei': '12.08'}",CHEMBL3263073,,CHEMBL3263073,7.80,0,http://www.openphacts.org/units/Nanomolar,2836946,=,37,1,=,,IC50,nM,,16.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,16.0
,323779,17702816,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(Cl)cc3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '13.26', 'le': '0.27', 'lle': '-0.60', 'sei': '12.22'}",CHEMBL3263074,,CHEMBL3263074,7.89,0,http://www.openphacts.org/units/Nanomolar,2836947,=,37,1,=,,IC50,nM,,13.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,13.0
,323780,17702817,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cccc(-c2nnc(Nc3ccccc3N3CC4(CCN(CC(C)(C)C)CC4)c4c(Cl)ccc(O)c43)s2)c1,,,CHEMBL3886218,,2015,"{'bei': '13.34', 'le': '0.26', 'lle': '-0.49', 'sei': '11.87'}",CHEMBL3929983,,CHEMBL3929983,7.66,0,http://www.openphacts.org/units/Nanomolar,2836948,=,37,1,=,,IC50,nM,,22.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,22.0
,323781,17702818,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cc(Cl)cc(Cl)c3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '12.27', 'le': '0.26', 'lle': '-1.43', 'sei': '11.97'}",CHEMBL3927367,,CHEMBL3927367,7.72,0,http://www.openphacts.org/units/Nanomolar,2836949,=,37,1,=,,IC50,nM,,19.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,19.0
,323782,17702819,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cc(F)ccc3Cl)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '12.33', 'le': '0.25', 'lle': '-1.08', 'sei': '11.71'}",CHEMBL3902900,,CHEMBL3902900,7.55,0,http://www.openphacts.org/units/Nanomolar,2836950,=,37,1,=,,IC50,nM,,28.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,28.0
,323783,17702820,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(Cl)c(Cl)c3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '12.27', 'le': '0.26', 'lle': '-1.43', 'sei': '11.97'}",CHEMBL3918409,,CHEMBL3918409,7.72,0,http://www.openphacts.org/units/Nanomolar,2836951,=,37,1,=,,IC50,nM,,19.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,19.0
,323784,17702821,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(OC(F)(F)F)cc3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '12.24', 'le': '0.24', 'lle': '-0.85', 'sei': '10.69'}",CHEMBL3263071,,CHEMBL3263071,7.89,0,http://www.openphacts.org/units/Nanomolar,2836952,=,37,1,=,,IC50,nM,,13.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,13.0
,323785,17702822,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cccc(C(F)(F)F)c3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '12.13', 'le': '0.24', 'lle': '-1.24', 'sei': '11.81'}",CHEMBL3890364,,CHEMBL3890364,7.62,0,http://www.openphacts.org/units/Nanomolar,2836953,=,37,1,=,,IC50,nM,,24.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,24.0
,323786,17702823,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccccn3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '14.55', 'le': '0.29', 'lle': '0.94', 'sei': '10.55'}",CHEMBL3932713,,CHEMBL3932713,8.17,0,http://www.openphacts.org/units/Nanomolar,2836954,=,37,1,=,,IC50,nM,,6.8,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,6.8
,323787,17702824,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3cccc(F)c3)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '13.21', 'le': '0.26', 'lle': '-0.34', 'sei': '11.84'}",CHEMBL3979693,,CHEMBL3979693,7.64,0,http://www.openphacts.org/units/Nanomolar,2836955,=,37,1,=,,IC50,nM,,23.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,23.0
,323788,17702825,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(OC(F)(F)F)cc3)s1)c1c(O)ccc(F)c12,,,CHEMBL3886218,,2015,"{'bei': '13.22', 'le': '0.26', 'lle': '0.08', 'sei': '11.26'}",CHEMBL3263070,,CHEMBL3263070,8.30,0,http://www.openphacts.org/units/Nanomolar,2836956,=,37,1,=,,IC50,nM,,5.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,5.0
,323789,17702826,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(Cl)cc3)s1)c1c(O)ccc(F)c12,,,CHEMBL3886218,,2015,"{'bei': '14.22', 'le': '0.28', 'lle': '0.24', 'sei': '12.74'}",CHEMBL3903953,,CHEMBL3903953,8.22,0,http://www.openphacts.org/units/Nanomolar,2836957,=,37,1,=,,IC50,nM,,6.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,6.0
,323790,17702827,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(OC(F)(F)F)cc3)s1)c1c(O)c(F)cc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '10.81', 'le': '0.22', 'lle': '-1.72', 'sei': '9.71'}",CHEMBL3974841,,CHEMBL3974841,7.16,0,http://www.openphacts.org/units/Nanomolar,2836958,=,37,1,=,,IC50,nM,,69.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,69.0
,323791,17702828,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(OC(F)(F)F)cc3)s1)c1c(O)cc(F)c(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '11.54', 'le': '0.23', 'lle': '-1.24', 'sei': '10.36'}",CHEMBL3893862,,CHEMBL3893862,7.64,0,http://www.openphacts.org/units/Nanomolar,2836959,=,37,1,=,,IC50,nM,,23.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,23.0
,323792,17702829,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(OC(F)(F)F)cc3)s1)c1c(O)cc(F)c(F)c12,,,CHEMBL3886218,,2015,"{'bei': '11.51', 'le': '0.23', 'lle': '-0.93', 'sei': '10.08'}",CHEMBL3968470,,CHEMBL3968470,7.43,0,http://www.openphacts.org/units/Nanomolar,2836960,=,37,1,=,,IC50,nM,,37.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,37.0
,323793,17702830,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nc(-c3ccccc3)ns1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '14.68', 'le': '0.29', 'lle': '0.38', 'sei': '12.74'}",CHEMBL3263058,,CHEMBL3263058,8.22,0,http://www.openphacts.org/units/Nanomolar,2836961,=,37,1,=,,IC50,nM,,6.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,6.0
,323794,17702831,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nc(C(C)(C)C)ns1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '14.99', 'le': '0.30', 'lle': '0.63', 'sei': '12.55'}",CHEMBL3967844,,CHEMBL3967844,8.10,0,http://www.openphacts.org/units/Nanomolar,2836962,=,37,1,=,,IC50,nM,,8.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,8.0
,323795,17702832,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1cc(-c3ccc(C(F)(F)F)cc3)on1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '11.82', 'le': '0.23', 'lle': '-1.77', 'sei': '11.15'}",CHEMBL3932841,,CHEMBL3932841,7.22,0,http://www.openphacts.org/units/Nanomolar,2836963,=,37,1,=,,IC50,nM,,60.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,60.0
,323796,17702833,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1cc(-c3ccccc3)on1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '13.22', 'le': '0.25', 'lle': '-0.80', 'sei': '11.09'}",CHEMBL3263060,,CHEMBL3263060,7.18,0,http://www.openphacts.org/units/Nanomolar,2836964,=,37,1,=,,IC50,nM,,66.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,66.0
,323797,17702834,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nc(C(C)(C)C)c(C#N)s1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '14.26', 'le': '0.28', 'lle': '0.10', 'sei': '10.67'}",CHEMBL3973199,,CHEMBL3973199,8.05,0,http://www.openphacts.org/units/Nanomolar,2836965,=,37,1,=,,IC50,nM,,9.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,9.0
,323798,17702835,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CCOC(=O)c1sc(Nc2ccccc2N2CC3(CCN(CC(C)(C)C)CC3)c3c(Cl)ccc(O)c32)nc1C(F)(F)F,,,CHEMBL3886218,,2015,"{'bei': '12.39', 'le': '0.25', 'lle': '-0.25', 'sei': '9.91'}",CHEMBL3905619,,CHEMBL3905619,7.72,0,http://www.openphacts.org/units/Nanomolar,2836966,=,37,1,=,,IC50,nM,,19.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,19.0
,323799,17702836,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)CN1CCc2nc(Nc3ccccc3N3CC4(CCN(CC(C)(C)C)CC4)c4c(Cl)ccc(O)c43)sc2C1,,,CHEMBL3886218,,2015,"{'bei': '12.92', 'le': '0.26', 'lle': '-0.11', 'sei': '13.99'}",CHEMBL3981201,,CHEMBL3981201,7.68,0,http://www.openphacts.org/units/Nanomolar,2836967,=,37,1,=,,IC50,nM,,21.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,21.0
,323800,17702837,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1ccc(C(F)(F)F)cn1)c1c(O)ccc(Cl)c12,,,CHEMBL3886218,,2015,"{'bei': '14.05', 'le': '0.28', 'lle': '-0.07', 'sei': '14.83'}",CHEMBL3911187,,CHEMBL3911187,7.66,0,http://www.openphacts.org/units/Nanomolar,2836968,=,37,1,=,,IC50,nM,,22.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,22.0
,323801,17702838,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)c1ccc(O)c2c1C1(CCN(CC(C)(C)C)CC1)CN2c1ccccc1Nc1nnc(-c2ccc(C(F)(F)F)cc2)s1,,,CHEMBL3886218,,2015,"{'bei': '12.42', 'le': '0.24', 'lle': '0.11', 'sei': '8.92'}",CHEMBL3926419,,CHEMBL3926419,8.10,0,http://www.openphacts.org/units/Nanomolar,2836969,=,37,1,=,,IC50,nM,,8.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,8.0
,323802,17702839,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)c1ccc(O)c2c1C1(CCN(CC(C)(C)C)CC1)CN2c1ccccc1Nc1nnc(-c2ccc(C(C)(C)C)cc2)s1,,,CHEMBL3886218,,2015,"{'bei': '12.65', 'le': '0.24', 'lle': '-0.17', 'sei': '8.92'}",CHEMBL3263069,,CHEMBL3263069,8.10,0,http://www.openphacts.org/units/Nanomolar,2836970,=,37,1,=,,IC50,nM,,8.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,8.0
,323803,17702840,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(C(F)(F)F)cc3)s1)c1c(O)ccc(C#N)c12,,,CHEMBL3886218,,2015,"{'bei': '13.77', 'le': '0.26', 'lle': '0.44', 'sei': '9.65'}",CHEMBL3920135,,CHEMBL3920135,8.52,0,http://www.openphacts.org/units/Nanomolar,2836971,=,37,1,=,,IC50,nM,,3.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,3.0
,323804,17702841,[],CHEMBL3887218,"Scintillation Proximity Assay (SPA) Assay: SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Yi receptors (The P2Yi receptor membranes were provided by Biology and the cloning of the receptor and P2Yi receptor membrane preparation is same as described by Biology). Binding reactions were performed in 384- well OptiPlates (PerkinElmer Life Sciences, Cat # 6007299) in a volume of 50 ui containing -15 fmol of P2Y1 receptor (1.7 ug of total protein), 0.3 nM [33P] 2MeS-ADP(PerkinElmer; 2,000 Ci/mmol), various concentrations of the test compound (usually between 10 uM and 160 pM) in Buffer B containing 1% DMSO in assay buffer (15 mM, HEPES, 145 mM potassium chloride, 5 mM sodium Chloride, 5 mM EDTA, 0.1 mM MgCl2, pH 7.4) and 100 ug of SPA bead (WGA polystyrene Image beads, #RPNQ 0260V, Amersham). Reactions were allowed to proceed to completion at room temperature for 1 hour followed by centrifugation of the plate for 5 min.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1Nc1nnc(-c3ccc(C(C)(C)C)cc3)s1)c1c(O)ccc(C#N)c12,,,CHEMBL3886218,,2015,"{'bei': '13.18', 'le': '0.25', 'lle': '-0.35', 'sei': '9.06'}",CHEMBL3263068,,CHEMBL3263068,8.00,0,http://www.openphacts.org/units/Nanomolar,2836972,=,37,1,=,,IC50,nM,,10.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,nM,UO_0000065,,10.0
,,18049706,[],CHEMBL4011251,Antagonist activity at human P2Y1 receptor transfected in human 1321N1 cells assessed as inhibition of ADP-activated intracellular calcium mobilization preincubated for 30 mins followed by ADP addition by fluo-4-dye based fluorescence assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1c(S(=O)(=O)[O-])cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O.[Na+],,,CHEMBL4007497,J Med Chem,2017,,CHEMBL256057,ACID BLUE 25,CHEMBL1206272,4.75,0,http://www.openphacts.org/units/Nanomolar,2991162,=,1,1,=,,IC50,nM,,17600.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,17.6
,,18049707,[],CHEMBL4011251,Antagonist activity at human P2Y1 receptor transfected in human 1321N1 cells assessed as inhibition of ADP-activated intracellular calcium mobilization preincubated for 30 mins followed by ADP addition by fluo-4-dye based fluorescence assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Nc2cc(S(=O)(=O)[O-])c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O.[Na+],,,CHEMBL4007497,J Med Chem,2017,,CHEMBL4069492,,CHEMBL4117118,5.12,0,http://www.openphacts.org/units/Nanomolar,2991198,=,1,1,=,,IC50,nM,,7650.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,7.65
,,18049708,[],CHEMBL4011251,Antagonist activity at human P2Y1 receptor transfected in human 1321N1 cells assessed as inhibition of ADP-activated intracellular calcium mobilization preincubated for 30 mins followed by ADP addition by fluo-4-dye based fluorescence assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)[O-])c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1.[Na+],,,CHEMBL4007497,J Med Chem,2017,,CHEMBL4087247,,CHEMBL4116405,5.26,0,http://www.openphacts.org/units/Nanomolar,2991217,=,1,1,=,,IC50,nM,,5480.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,5.48
,,18049709,[],CHEMBL4011251,Antagonist activity at human P2Y1 receptor transfected in human 1321N1 cells assessed as inhibition of ADP-activated intracellular calcium mobilization preincubated for 30 mins followed by ADP addition by fluo-4-dye based fluorescence assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)[O-])c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1.[Na+],,,CHEMBL4007497,J Med Chem,2017,,CHEMBL4081274,,CHEMBL4116838,5.57,0,http://www.openphacts.org/units/Nanomolar,2991218,=,1,1,=,,IC50,nM,,2720.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.72
,,18049710,[],CHEMBL4011251,Antagonist activity at human P2Y1 receptor transfected in human 1321N1 cells assessed as inhibition of ADP-activated intracellular calcium mobilization preincubated for 30 mins followed by ADP addition by fluo-4-dye based fluorescence assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)[O-])c(N)c4c3C(=O)c3ccccc3C4=O)cc2)cc1C.[Na+],,,CHEMBL4007497,J Med Chem,2017,,CHEMBL4099292,,CHEMBL4116316,5.34,0,http://www.openphacts.org/units/Nanomolar,2991219,=,1,1,=,,IC50,nM,,4550.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,4.55
,,18049711,[],CHEMBL4011251,Antagonist activity at human P2Y1 receptor transfected in human 1321N1 cells assessed as inhibition of ADP-activated intracellular calcium mobilization preincubated for 30 mins followed by ADP addition by fluo-4-dye based fluorescence assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O.[Na+],,,CHEMBL4007497,J Med Chem,2017,,CHEMBL4090874,,CHEMBL4116755,4.60,0,http://www.openphacts.org/units/Nanomolar,2991220,=,1,1,=,,IC50,nM,,25000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,25.0
,,18488156,[],CHEMBL4186854,Antagonist activity at P2Y1 receptor (unknown origin),F,,,BAO_0000190,BAO_0000019,assay format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL4184187,Bioorg Med Chem,2018,,CHEMBL129841,,CHEMBL129841,6.48,0,http://www.openphacts.org/units/Nanomolar,3068722,=,1,1,=,,IC50,nM,,330.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.33
,,18488157,[],CHEMBL4186854,Antagonist activity at P2Y1 receptor (unknown origin),F,,,BAO_0000190,BAO_0000019,assay format,CNc1ncnc2c1ncn2[C@@H]1C[C@H](COP(=O)(O)O)[C@@H](OP(=O)(O)O)C1,,,CHEMBL4184187,Bioorg Med Chem,2018,,CHEMBL4214232,,CHEMBL4214232,6.83,0,http://www.openphacts.org/units/Nanomolar,3068723,=,1,1,=,,IC50,nM,,148.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.148
,,18488158,[],CHEMBL4186854,Antagonist activity at P2Y1 receptor (unknown origin),F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@]2(COP(=O)(O)O)C[C@H]12,,,CHEMBL4184187,Bioorg Med Chem,2018,,CHEMBL2112864,,CHEMBL2112864,7.28,0,http://www.openphacts.org/units/Nanomolar,3068724,=,1,1,=,,IC50,nM,,52.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.052
,,18768817,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1ccc(NC(=O)Nc2cccnc2Oc2ccccc2C(C)(C)C)s1,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL4278771,,CHEMBL4278771,4.89,0,http://www.openphacts.org/units/Nanomolar,3118469,=,1,1,=,,IC50,nM,,12920.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,12.92
,,18768818,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1ccc(NC(=O)Nc2cccnc2Oc2ccccc2C(C)(C)C)s1,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL4284352,,CHEMBL4284352,4.90,0,http://www.openphacts.org/units/Nanomolar,3118470,=,1,1,=,,IC50,nM,,12520.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,12.52
,,18768819,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccccc1Oc1ncccc1NC(=O)Nc1ccc(C(=O)OCc2ccccc2)s1,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL4292253,,CHEMBL4292253,5.14,0,http://www.openphacts.org/units/Nanomolar,3118471,=,1,1,=,,IC50,nM,,7190.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,7.19
,,18768820,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCCNC(=O)Nc1cccnc1Oc1ccccc1C(C)(C)C,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL4287760,,CHEMBL4287760,5.00,0,http://www.openphacts.org/units/Nanomolar,3118476,=,1,1,=,,IC50,nM,,9980.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,9.98
,,18768821,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccccc1Oc1ncccc1NC(=O)N[C@H]1CC[C@H](C)CC1,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL4277104,,CHEMBL4277104,5.15,0,http://www.openphacts.org/units/Nanomolar,3118477,=,1,1,=,,IC50,nM,,7050.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,7.05
,,18768822,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccccc1Oc1ncccc1NC(=O)NC1CCCC1,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL4279409,,CHEMBL4279409,5.62,0,http://www.openphacts.org/units/Nanomolar,3118478,=,1,1,=,,IC50,nM,,2410.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,2.41
,,18768823,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccccc1Oc1ncccc1NC(=O)NC1C2CC3CC(C2)CC1C3,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL4287333,,CHEMBL4287333,6.21,0,http://www.openphacts.org/units/Nanomolar,3118479,=,1,1,=,,IC50,nM,,620.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.62
,,18768824,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC1CCCCC1NC(=O)Nc1cccnc1Oc1ccccc1C(C)(C)C,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL4280909,,CHEMBL4280909,6.09,0,http://www.openphacts.org/units/Nanomolar,3118480,=,1,1,=,,IC50,nM,,820.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.82
,,18768825,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)c(Oc2ccccc2C(C)(C)C)n1,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL4276825,,CHEMBL4276825,6.68,0,http://www.openphacts.org/units/Nanomolar,3118481,=,1,1,=,,IC50,nM,,210.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.21
,,18768826,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccccc1Oc1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL4294630,,CHEMBL4294630,5.12,0,http://www.openphacts.org/units/Nanomolar,3118482,=,1,1,=,,IC50,nM,,7530.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,7.53
,,18768827,[],CHEMBL4267870,Antagonist activity at P2Y1 (unknown origin) expressed in human 1321N1 cells assessed as induction of calcium stimulation by fluo-4 dye based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccccc1Oc1ncccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1,,,CHEMBL4265928,Eur J Med Chem,2018,,CHEMBL2333770,,CHEMBL2333770,6.55,0,http://www.openphacts.org/units/Nanomolar,3118484,=,1,1,=,,IC50,nM,,280.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.28
,,19406372,[],CHEMBL4426493,Antagonist activity human P2Y1R expressed in human 1321N1 cells assessed as inhibition of 2MeSADP-induced [3H]inositol phosphate accumulation after 30 mins by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,,,CHEMBL4425123,J Med Chem,2016,,CHEMBL1800685,PPTN,CHEMBL1800685,,1,http://www.openphacts.org/units/Nanomolar,3243465,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24773444,[],CHEMBL5127323,Antagonist activity at P2Y1 receptor (unknown origin),F,,,BAO_0000190,BAO_0000019,assay format,CNc1ncnc2c1ncn2CCC(COP(=O)(O)O)COP(=O)(O)O,,,CHEMBL5126515,Eur J Med Chem,2022,,CHEMBL432028,,CHEMBL432028,6.32,0,http://www.openphacts.org/units/Nanomolar,3865840,=,1,1,=,,IC50,nM,,480.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.48
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24773445,[],CHEMBL5127323,Antagonist activity at P2Y1 receptor (unknown origin),F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc(Cl)nc2c1ncn2CCC(COP(=O)(O)O)COP(=O)(O)O,,,CHEMBL5126515,Eur J Med Chem,2022,,CHEMBL108166,,CHEMBL108166,5.80,0,http://www.openphacts.org/units/Nanomolar,3865841,=,1,1,=,,IC50,nM,,1600.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.6
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24773446,[],CHEMBL5127323,Antagonist activity at P2Y1 receptor (unknown origin),F,,,BAO_0000190,BAO_0000019,assay format,CNc1ncnc2c1ncn2CC(COP(=O)(O)O)COP(=O)(O)O,,,CHEMBL5126515,Eur J Med Chem,2022,,CHEMBL320924,,CHEMBL320924,5.96,0,http://www.openphacts.org/units/Nanomolar,3865842,=,1,1,=,,IC50,nM,,1090.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,1.09
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24773447,[],CHEMBL5127323,Antagonist activity at P2Y1 receptor (unknown origin),F,,,BAO_0000190,BAO_0000019,assay format,CNc1nc(Cl)nc2c1ncn2CC(COP(=O)(O)O)COP(=O)(O)O,,,CHEMBL5126515,Eur J Med Chem,2022,,CHEMBL104784,,CHEMBL104784,6.08,0,http://www.openphacts.org/units/Nanomolar,3865843,=,1,1,=,,IC50,nM,,840.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.84
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24871770,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '0.5'}]",CHEMBL5153130,Antagonist activity at human P2Y1R expressed in HEK293 cells assessed as inhibition of ADP-induced IP3 production preincubated for 0.5 hrs followed by ADP stimulation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccccc1Oc1ncccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1,,,CHEMBL5150046,J Med Chem,2022,,CHEMBL2333770,,CHEMBL2333770,6.46,0,http://www.openphacts.org/units/Nanomolar,3886725,=,1,1,=,,IC50,nM,,350.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,0.35
,,24871837,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.25', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '15.0'}]",CHEMBL5153183,Antagonist activity at P2Y1R (unknown origin) expressed in human 1321N1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated for 15 mins in presence of IBMX by chromatography,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,,,CHEMBL5150046,J Med Chem,2022,,CHEMBL1800685,PPTN,CHEMBL1800685,,0,http://www.openphacts.org/units/Nanomolar,3886728,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4315,Homo sapiens,Purinergic receptor P2Y1,9606,,,IC50,uM,UO_0000065,,10.0
